# EDGAR Filing Document

**Accession Number:** 0001378872
**File Stem:** 0001378872-26-000281
**Filing Date:** 2026-1
**Character Count:** 165035
**Document Hash:** 0b38cd9fe3fc82582c49031a4e5536e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001378872-26-000281.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001378872-26-000281

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251130

**FILED AS OF DATE**: 20260128

**DATE AS OF CHANGE**: 20260128

**PERIOD START**: 20260831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Invesco Exchange-Traded Fund Trust II
- **CENTRAL INDEX KEY:** 0001378872

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21977
- **FILM NUMBER:** 26571908

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PowerShares Exchange-Traded Fund Trust II
- **DATE OF NAME CHANGE:** 20070919

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PowerShares Global Exchange-Traded Fund Trust
- **DATE OF NAME CHANGE:** 20061023

## Series and Classes Contracts Data

### Invesco NASDAQ Future Gen 200 ETF (Series ID: S000077288)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000237581 | Invesco NASDAQ Future Gen 200 ETF | QQQS            |

## Nport-Ex

Schedule of Investments<sup>(a)</sup>

**Invesco ESG NASDAQ 100 ETF (QQMG)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** | **Common Stocks & Other Equity Interests-99.97%** |
| **Communication Services-12.92%** | **Communication Services-12.92%** | **Communication Services-12.92%** |
| Alphabet, Inc., Class A | 13047 | &nbsp;&nbsp; $4177388 |
| Alphabet, Inc., Class C | 12179 | &nbsp;&nbsp; 3898742 |
| Charter Communications, Inc., Class A<sup>(b)(c)</sup> | 834 | &nbsp;&nbsp; 166900 |
| Comcast Corp., Class A | 25164 | &nbsp;&nbsp; 671627 |
| Electronic Arts, Inc. | 2657 | &nbsp;&nbsp; 536794 |
| Meta Platforms, Inc., Class A | 2412 | &nbsp;&nbsp; 1562855 |
| Netflix, Inc.<sup>(b)</sup> | 38970 | &nbsp;&nbsp; 4192393 |
| Take-Two Interactive Software, Inc.<sup>(b)</sup> | 1759 | &nbsp;&nbsp; 432837 |
| T-Mobile US, Inc. | 7207 | &nbsp;&nbsp; 1506335 |
| Trade Desk, Inc. (The), Class A<sup>(b)</sup> | 3010 | &nbsp;&nbsp; 119076 |
| Warner Bros. Discovery, Inc.<sup>(b)</sup> | 24881 | &nbsp;&nbsp; 597144 |
|  |  | &nbsp;&nbsp; 17862091 |
| **Consumer Discretionary-10.84%** | **Consumer Discretionary-10.84%** | **Consumer Discretionary-10.84%** |
| Airbnb, Inc., Class A<sup>(b)</sup> | 3693 | &nbsp;&nbsp; 432044 |
| Amazon.com, Inc.<sup>(b)</sup> | 20651 | &nbsp;&nbsp; 4816226 |
| Booking Holdings, Inc. | 317 | &nbsp;&nbsp; 1557957 |
| DoorDash, Inc., Class A<sup>(b)</sup> | 2511 | &nbsp;&nbsp; 498107 |
| lululemon athletica, Inc.<sup>(b)</sup> | 1123 | &nbsp;&nbsp; 206834 |
| Marriott International, Inc., Class A | 1954 | &nbsp;&nbsp; 595560 |
| MercadoLibre, Inc. (Brazil)<sup>(b)</sup> | 412 | &nbsp;&nbsp; 853573 |
| O'Reilly Automotive, Inc.<sup>(b)</sup> | 9103 | &nbsp;&nbsp; 925775 |
| PDD Holdings, Inc., ADR (China)<sup>(b)</sup> | 2799 | &nbsp;&nbsp; 324908 |
| Ross Stores, Inc. | 2486 | &nbsp;&nbsp; 438431 |
| Starbucks Corp. | 7386 | &nbsp;&nbsp; 643394 |
| Tesla, Inc.<sup>(b)</sup> | 8580 | &nbsp;&nbsp; 3690859 |
|  |  | &nbsp;&nbsp; 14983668 |
| **Consumer Staples-3.51%** | **Consumer Staples-3.51%** | **Consumer Staples-3.51%** |
| &nbsp;&nbsp;&nbsp; Coca-Cola Europacific Partners PLC (United <br> Kingdom)<br>| 4011 | &nbsp;&nbsp; 367769 |
| Costco Wholesale Corp. | 1855 | &nbsp;&nbsp; 1694709 |
| Keurig Dr Pepper, Inc. | 8392 | &nbsp;&nbsp; 234137 |
| Kraft Heinz Co. (The) | 5503 | &nbsp;&nbsp; 140382 |
| Mondelez International, Inc., Class A | 8792 | &nbsp;&nbsp; 506155 |
| Monster Beverage Corp.<sup>(b)</sup> | 4078 | &nbsp;&nbsp; 305809 |
| PepsiCo, Inc. | 10738 | &nbsp;&nbsp; 1597170 |
|  |  | &nbsp;&nbsp; 4846131 |
| **Financials-0.35%** | **Financials-0.35%** | **Financials-0.35%** |
| PayPal Holdings, Inc. | 7625 | &nbsp;&nbsp; 478011 |
| **Health Care-5.14%** | **Health Care-5.14%** | **Health Care-5.14%** |
| Amgen, Inc. | 3619 | &nbsp;&nbsp; 1250220 |
| AstraZeneca PLC, ADR (United Kingdom) | 3768 | &nbsp;&nbsp; 349369 |
| Biogen, Inc.<sup>(b)</sup> | 1146 | &nbsp;&nbsp; 208675 |
| DexCom, Inc.<sup>(b)</sup> | 2941 | &nbsp;&nbsp; 186665 |
| GE HealthCare Technologies, Inc. | 3240 | &nbsp;&nbsp; 259168 |
| Gilead Sciences, Inc. | 8592 | &nbsp;&nbsp; 1081217 |
| IDEXX Laboratories, Inc.<sup>(b)</sup> | 761 | &nbsp;&nbsp; 572942 |
| Intuitive Surgical, Inc.<sup>(b)</sup> | 3024 | &nbsp;&nbsp; 1734203 |
| Regeneron Pharmaceuticals, Inc. | 832 | &nbsp;&nbsp; 649118 |
| Vertex Pharmaceuticals, Inc.<sup>(b)</sup> | 1867 | &nbsp;&nbsp; 809550 |
|  |  | &nbsp;&nbsp; 7101127 |
| **Industrials-2.95%** | **Industrials-2.95%** | **Industrials-2.95%** |
| Automatic Data Processing, Inc. | 3832 | &nbsp;&nbsp; 978309 |
| Cintas Corp. | 3584 | &nbsp;&nbsp; 666696 |
| Copart, Inc.<sup>(b)</sup> | 8057 | &nbsp;&nbsp; 314062 |
| Fastenal Co. | 9304 | &nbsp;&nbsp; 375882 |
| Old Dominion Freight Line, Inc. | 1946 | &nbsp;&nbsp; 263274 |
| PACCAR, Inc. | 1755 | &nbsp;&nbsp; 185012 |
| Paychex, Inc. | 3007 | &nbsp;&nbsp; 335852 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Thomson Reuters Corp. (Canada) | 5114 | &nbsp;&nbsp; $692589 |
| Verisk Analytics, Inc. | 1183 | &nbsp;&nbsp; 266258 |
|  |  | &nbsp;&nbsp; 4077934 |
| **Information Technology-62.36%** | **Information Technology-62.36%** | **Information Technology-62.36%** |
| Adobe, Inc.<sup>(b)</sup> | 4155 | &nbsp;&nbsp; 1330140 |
| Advanced Micro Devices, Inc.<sup>(b)</sup> | 16962 | &nbsp;&nbsp; 3689744 |
| Apple, Inc. | 42471 | &nbsp;&nbsp; 11843038 |
| Applied Materials, Inc. | 8211 | &nbsp;&nbsp; 2071225 |
| AppLovin Corp., Class A<sup>(b)</sup> | 2779 | &nbsp;&nbsp; 1665955 |
| &nbsp;&nbsp;&nbsp; ASML Holding N.V., New York Shares <br> (Netherlands)<br>| 962 | &nbsp;&nbsp; 1019720 |
| Atlassian Corp., Class A<sup>(b)</sup> | 1415 | &nbsp;&nbsp; 211571 |
| Autodesk, Inc.<sup>(b)</sup> | 1991 | &nbsp;&nbsp; 603950 |
| Broadcom, Inc. | 21934 | &nbsp;&nbsp; 8838525 |
| Cadence Design Systems, Inc.<sup>(b)</sup> | 2644 | &nbsp;&nbsp; 824505 |
| CDW Corp. | 1621 | &nbsp;&nbsp; 233781 |
| Cisco Systems, Inc. | 40744 | &nbsp;&nbsp; 3134843 |
| Cognizant Technology Solutions Corp., Class A | 4095 | &nbsp;&nbsp; 318222 |
| CrowdStrike Holdings, Inc., Class A<sup>(b)</sup> | 2047 | &nbsp;&nbsp; 1042251 |
| Datadog, Inc., Class A<sup>(b)</sup> | 2917 | &nbsp;&nbsp; 466749 |
| Fortinet, Inc.<sup>(b)</sup> | 7030 | &nbsp;&nbsp; 570344 |
| GLOBALFOUNDRIES, Inc.<sup>(b)(c)</sup> | 4875 | &nbsp;&nbsp; 174720 |
| Intel Corp.<sup>(b)</sup> | 35245 | &nbsp;&nbsp; 1429537 |
| Intuit, Inc. | 2824 | &nbsp;&nbsp; 1790642 |
| KLA Corp. | 1361 | &nbsp;&nbsp; 1599815 |
| Lam Research Corp. | 12885 | &nbsp;&nbsp; 2010060 |
| Marvell Technology, Inc. | 8497 | &nbsp;&nbsp; 759632 |
| Microchip Technology, Inc. | 3309 | &nbsp;&nbsp; 177296 |
| Micron Technology, Inc. | 9020 | &nbsp;&nbsp; 2133050 |
| Microsoft Corp. | 23265 | &nbsp;&nbsp; 11446613 |
| NVIDIA Corp. | 91883 | &nbsp;&nbsp; 16263291 |
| NXP Semiconductors N.V. (Netherlands) | 2228 | &nbsp;&nbsp; 434326 |
| ON Semiconductor Corp.<sup>(b)</sup> | 2914 | &nbsp;&nbsp; 146399 |
| Palantir Technologies, Inc., Class A<sup>(b)</sup> | 16061 | &nbsp;&nbsp; 2705475 |
| Palo Alto Networks, Inc.<sup>(b)</sup> | 6885 | &nbsp;&nbsp; 1309045 |
| QUALCOMM, Inc. | 10810 | &nbsp;&nbsp; 1817053 |
| Roper Technologies, Inc. | 746 | &nbsp;&nbsp; 332880 |
| Shopify, Inc., Class A (Canada)<sup>(b)</sup> | 6608 | &nbsp;&nbsp; 1048293 |
| Strategy, Inc., Class A<sup>(b)</sup> | 897 | &nbsp;&nbsp; 158930 |
| Synopsys, Inc.<sup>(b)</sup> | 1610 | &nbsp;&nbsp; 672996 |
| Texas Instruments, Inc. | 6873 | &nbsp;&nbsp; 1156520 |
| Workday, Inc., Class A<sup>(b)</sup> | 1961 | &nbsp;&nbsp; 422831 |
| Zscaler, Inc.<sup>(b)</sup> | 1276 | &nbsp;&nbsp; 320914 |
|  |  | &nbsp;&nbsp; 86174881 |
| **Materials-1.50%** | **Materials-1.50%** | **Materials-1.50%** |
| Linde PLC | 5039 | &nbsp;&nbsp; 2067602 |
| **Real Estate-0.15%** | **Real Estate-0.15%** | **Real Estate-0.15%** |
| CoStar Group, Inc.<sup>(b)</sup> | 3076 | &nbsp;&nbsp; 211629 |
| **Utilities-0.25%** | **Utilities-0.25%** | **Utilities-0.25%** |
| Exelon Corp. | 7240 | &nbsp;&nbsp; 341149 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $110,197,460) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $110,197,460) | &nbsp;&nbsp; 138144223 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco ESG NASDAQ 100 ETF (QQMG)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Money Market Funds-0.00%** | **Money Market Funds-0.00%** | **Money Market Funds-0.00%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.91%<sup>(d)(e)</sup> <br>(Cost $4,943)<br>| 4943 | &nbsp;&nbsp; $4943 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.97% <br>(Cost $110,202,403) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.97% <br>(Cost $110,202,403) | &nbsp;&nbsp; 138149166 |
| **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** |
| **Money Market Funds-0.24%** | **Money Market Funds-0.24%** | **Money Market Funds-0.24%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 4.00%<sup>(d)(e)(f)</sup><br>| 95228 | &nbsp;&nbsp; 95228 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Money Market Funds-(continued)** | **Money Market Funds-(continued)** | **Money Market Funds-(continued)** |
| Invesco Private Prime Fund, 4.12%<sup>(d)(e)(f)</sup> | 243013 | &nbsp;&nbsp; $243086 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $338,314) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $338,314) | &nbsp;&nbsp; 338314 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-100.21% <br>(Cost $110,540,717) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-100.21% <br>(Cost $110,540,717) | &nbsp;&nbsp; 138487480 |
| OTHER ASSETS LESS LIABILITIES-(0.21)% | OTHER ASSETS LESS LIABILITIES-(0.21)% | &nbsp;&nbsp; (295541)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $138191939 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2025. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the three months ended November 30, 2025.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $18764 | &nbsp;&nbsp;&nbsp; $234358 | &nbsp;&nbsp;&nbsp; $(248179)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $4943 | &nbsp;&nbsp;&nbsp; $636 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 34252 | &nbsp;&nbsp;&nbsp; 1287286 | &nbsp;&nbsp;&nbsp; (1226310)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 95228 | &nbsp;&nbsp;&nbsp; 645<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime <br> Fund<br>| &nbsp;&nbsp;&nbsp; 89034 | &nbsp;&nbsp;&nbsp; 3071327 | &nbsp;&nbsp;&nbsp; (2917378)<br>| &nbsp;&nbsp;&nbsp; (3)<br>| &nbsp;&nbsp;&nbsp; 106 | &nbsp;&nbsp;&nbsp; 243086 | &nbsp;&nbsp;&nbsp; 1,794<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $142050 | &nbsp;&nbsp;&nbsp; $4592971 | &nbsp;&nbsp;&nbsp; $(4391867)<br>| &nbsp;&nbsp;&nbsp; $(3)<br>| &nbsp;&nbsp;&nbsp; $106 | &nbsp;&nbsp;&nbsp; $343257 | &nbsp;&nbsp;&nbsp; $3075 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2025. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.90%** | **Common Stocks & Other Equity Interests-99.90%** | **Common Stocks & Other Equity Interests-99.90%** |
| **Communication Services-6.41%** | **Communication Services-6.41%** | **Communication Services-6.41%** |
| Fox Corp., Class A | 1290 | &nbsp;&nbsp; $84495 |
| Fox Corp., Class B | 1448 | &nbsp;&nbsp; 84360 |
| GCI Liberty, Inc., Class A<sup>(b)</sup> | 7 | &nbsp;&nbsp; 233 |
| GCI Liberty, Inc., Class C<sup>(b)</sup> | 47 | &nbsp;&nbsp; 1566 |
| GCI Liberty, Inc., Rts., expiring 12/17/2025<sup>(b)</sup> | 20 | &nbsp;&nbsp; 124 |
| Liberty Broadband Corp., Class A<sup>(b)</sup> | 34 | &nbsp;&nbsp; 1575 |
| Liberty Broadband Corp., Class C<sup>(b)</sup> | 240 | &nbsp;&nbsp; 11110 |
| Liberty Media Corp.-Liberty Formula One<sup>(b)</sup> | 981 | &nbsp;&nbsp; 94156 |
| Liberty Media Corp.-Liberty Formula One<sup>(b)</sup> | 104 | &nbsp;&nbsp; 9140 |
| NetEase, Inc., ADR (China) | 462 | &nbsp;&nbsp; 63779 |
| News Corp., Class A | 2283 | &nbsp;&nbsp; 58627 |
| News Corp., Class B | 1143 | &nbsp;&nbsp; 33639 |
|  |  | &nbsp;&nbsp; 442804 |
| **Consumer Discretionary-11.87%** | **Consumer Discretionary-11.87%** | **Consumer Discretionary-11.87%** |
| Duolingo, Inc.<sup>(b)</sup> | 133 | &nbsp;&nbsp; 25458 |
| eBay, Inc. | 2059 | &nbsp;&nbsp; 170465 |
| Expedia Group, Inc. | 451 | &nbsp;&nbsp; 115316 |
| JD.com, Inc., ADR (China)<sup>(c)</sup> | 1401 | &nbsp;&nbsp; 41792 |
| Pool Corp. | 228 | &nbsp;&nbsp; 55541 |
| Rivian Automotive, Inc., Class A<sup>(b)(c)</sup> | 3118 | &nbsp;&nbsp; 52569 |
| Tractor Supply Co. | 2889 | &nbsp;&nbsp; 158259 |
| Trip.com Group Ltd., ADR (China)<sup>(c)</sup> | 980 | &nbsp;&nbsp; 68522 |
| Ulta Beauty, Inc.<sup>(b)</sup> | 244 | &nbsp;&nbsp; 131474 |
|  |  | &nbsp;&nbsp; 819396 |
| **Consumer Staples-2.30%** | **Consumer Staples-2.30%** | **Consumer Staples-2.30%** |
| Campbell's Co. (The)<sup>(c)</sup> | 808 | &nbsp;&nbsp; 24628 |
| Dollar Tree, Inc.<sup>(b)(c)</sup> | 973 | &nbsp;&nbsp; 107818 |
| Sprouts Farmers Market, Inc.<sup>(b)</sup> | 314 | &nbsp;&nbsp; 26316 |
|  |  | &nbsp;&nbsp; 158762 |
| **Financials-1.72%** | **Financials-1.72%** | **Financials-1.72%** |
| Affirm Holdings, Inc.<sup>(b)</sup> | 1010 | &nbsp;&nbsp; 71660 |
| Jack Henry & Associates, Inc. | 271 | &nbsp;&nbsp; 47284 |
|  |  | &nbsp;&nbsp; 118944 |
| **Health Care-21.69%** | **Health Care-21.69%** | **Health Care-21.69%** |
| Align Technology, Inc.<sup>(b)</sup> | 329 | &nbsp;&nbsp; 48425 |
| Alnylam Pharmaceuticals, Inc.<sup>(b)</sup> | 410 | &nbsp;&nbsp; 185004 |
| argenx SE, ADR (Netherlands)<sup>(b)</sup> | 94 | &nbsp;&nbsp; 85726 |
| BioMarin Pharmaceutical, Inc.<sup>(b)</sup> | 614 | &nbsp;&nbsp; 34341 |
| BioNTech SE, ADR (Germany)<sup>(b)</sup> | 326 | &nbsp;&nbsp; 33627 |
| Bio-Techne Corp.<sup>(c)</sup> | 410 | &nbsp;&nbsp; 26449 |
| Cooper Cos., Inc. (The)<sup>(b)</sup> | 1042 | &nbsp;&nbsp; 81203 |
| Hologic, Inc.<sup>(b)</sup> | 839 | &nbsp;&nbsp; 62900 |
| ICON PLC<sup>(b)</sup> | 408 | &nbsp;&nbsp; 75480 |
| Illumina, Inc.<sup>(b)</sup> | 704 | &nbsp;&nbsp; 92541 |
| Incyte Corp.<sup>(b)</sup> | 662 | &nbsp;&nbsp; 69153 |
| Insmed, Inc.<sup>(b)</sup> | 621 | &nbsp;&nbsp; 129025 |
| Insulet Corp.<sup>(b)</sup> | 307 | &nbsp;&nbsp; 100447 |
| Medpace Holdings, Inc.<sup>(b)</sup> | 119 | &nbsp;&nbsp; 70503 |
| Moderna, Inc.<sup>(b)(c)</sup> | 1678 | &nbsp;&nbsp; 43594 |
| Natera, Inc.<sup>(b)</sup> | 316 | &nbsp;&nbsp; 75464 |
| Neurocrine Biosciences, Inc.<sup>(b)</sup> | 371 | &nbsp;&nbsp; 56451 |
| Royalty Pharma PLC, Class A | 969 | &nbsp;&nbsp; 38779 |
| Sanofi S.A., ADR | 1170 | &nbsp;&nbsp; 58360 |
| Sarepta Therapeutics, Inc.<sup>(b)(c)</sup> | 208 | &nbsp;&nbsp; 4439 |
| Summit Therapeutics, Inc.<sup>(b)(c)</sup> | 384 | &nbsp;&nbsp; 6870 |
| United Therapeutics Corp.<sup>(b)</sup> | 157 | &nbsp;&nbsp; 76302 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| Vaxcyte, Inc.<sup>(b)(c)</sup> | 124 | &nbsp;&nbsp; $6152 |
| Viatris, Inc. | 3409 | &nbsp;&nbsp; 36442 |
|  |  | &nbsp;&nbsp; 1497677 |
| **Industrials-9.53%** | **Industrials-9.53%** | **Industrials-9.53%** |
| AAON, Inc. | 313 | &nbsp;&nbsp; 29259 |
| C.H. Robinson Worldwide, Inc. | 551 | &nbsp;&nbsp; 87537 |
| Grab Holdings Ltd., Class A (Singapore)<sup>(b)</sup> | 13811 | &nbsp;&nbsp; 75270 |
| J.B. Hunt Transport Services, Inc. | 380 | &nbsp;&nbsp; 66105 |
| Lincoln Electric Holdings, Inc. | 164 | &nbsp;&nbsp; 39267 |
| Nordson Corp. | 152 | &nbsp;&nbsp; 36124 |
| Paylocity Holding Corp.<sup>(b)</sup> | 221 | &nbsp;&nbsp; 32560 |
| Ryanair Holdings PLC, ADR (Italy)<sup>(c)</sup> | 863 | &nbsp;&nbsp; 58822 |
| Saia, Inc.<sup>(b)</sup> | 121 | &nbsp;&nbsp; 34069 |
| SS&C Technologies Holdings, Inc. | 890 | &nbsp;&nbsp; 76487 |
| Tetra Tech, Inc. | 960 | &nbsp;&nbsp; 33350 |
| United Airlines Holdings, Inc.<sup>(b)</sup> | 873 | &nbsp;&nbsp; 89011 |
|  |  | &nbsp;&nbsp; 657861 |
| **Information Technology-44.66%** | **Information Technology-44.66%** | **Information Technology-44.66%** |
| Akamai Technologies, Inc.<sup>(b)</sup> | 720 | &nbsp;&nbsp; 64454 |
| Astera Labs, Inc.<sup>(b)</sup> | 611 | &nbsp;&nbsp; 96275 |
| Bentley Systems, Inc., Class B | 1374 | &nbsp;&nbsp; 57653 |
| Check Point Software Technologies Ltd. (Israel)<sup>(b)</sup> | 498 | &nbsp;&nbsp; 93012 |
| CyberArk Software Ltd.<sup>(b)</sup> | 227 | &nbsp;&nbsp; 104100 |
| DocuSign, Inc.<sup>(b)</sup> | 1028 | &nbsp;&nbsp; 71292 |
| Entegris, Inc. | 658 | &nbsp;&nbsp; 50758 |
| F5, Inc.<sup>(b)</sup> | 261 | &nbsp;&nbsp; 62421 |
| First Solar, Inc.<sup>(b)</sup> | 484 | &nbsp;&nbsp; 132093 |
| Flex Ltd.<sup>(b)</sup> | 2529 | &nbsp;&nbsp; 149489 |
| Gen Digital, Inc. | 3266 | &nbsp;&nbsp; 86124 |
| &nbsp;&nbsp;&nbsp; Logitech International S.A., Class R <br> (Switzerland)<sup>(c)</sup><br>| 922 | &nbsp;&nbsp; 103937 |
| Manhattan Associates, Inc.<sup>(b)</sup> | 291 | &nbsp;&nbsp; 51347 |
| Monday.com Ltd.<sup>(b)</sup> | 227 | &nbsp;&nbsp; 32656 |
| Monolithic Power Systems, Inc. | 228 | &nbsp;&nbsp; 211623 |
| NetApp, Inc. | 1087 | &nbsp;&nbsp; 121266 |
| Nutanix, Inc., Class A<sup>(b)</sup> | 1054 | &nbsp;&nbsp; 50381 |
| Okta, Inc.<sup>(b)(c)</sup> | 843 | &nbsp;&nbsp; 67718 |
| PTC, Inc.<sup>(b)</sup> | 610 | &nbsp;&nbsp; 107012 |
| Seagate Technology Holdings PLC | 1259 | &nbsp;&nbsp; 348353 |
| Skyworks Solutions, Inc. | 490 | &nbsp;&nbsp; 32316 |
| Super Micro Computer, Inc.<sup>(b)(c)</sup> | 2623 | &nbsp;&nbsp; 88789 |
| Teradyne, Inc. | 806 | &nbsp;&nbsp; 146603 |
| Trimble, Inc.<sup>(b)</sup> | 1506 | &nbsp;&nbsp; 122619 |
| VeriSign, Inc. | 358 | &nbsp;&nbsp; 90213 |
| Western Digital Corp. | 2000 | &nbsp;&nbsp; 326660 |
| Wix.com Ltd. (Israel)<sup>(b)</sup> | 237 | &nbsp;&nbsp; 22683 |
| Zebra Technologies Corp., Class A<sup>(b)</sup> | 308 | &nbsp;&nbsp; 77847 |
| Zoom Communications, Inc., Class A<sup>(b)</sup> | 1344 | &nbsp;&nbsp; 114186 |
|  |  | &nbsp;&nbsp; 3083880 |
| **Materials-0.58%** | **Materials-0.58%** | **Materials-0.58%** |
| Steel Dynamics, Inc. | 240 | &nbsp;&nbsp; 40279 |
| **Real Estate-1.14%** | **Real Estate-1.14%** | **Real Estate-1.14%** |
| Zillow Group, Inc., Class A<sup>(b)</sup> | 226 | &nbsp;&nbsp; 16351 |
| Zillow Group, Inc., Class C<sup>(b)</sup> | 839 | &nbsp;&nbsp; 62405 |
|  |  | &nbsp;&nbsp; 78756 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $5,454,389) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $5,454,389) | &nbsp;&nbsp; 6898359 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Money Market Funds-0.07%** | **Money Market Funds-0.07%** | **Money Market Funds-0.07%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.91%<sup>(d)(e)</sup> <br>(Cost $4,690)<br>| 4690 | &nbsp;&nbsp; $4690 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-99.97% <br>(Cost $5,459,079) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-99.97% <br>(Cost $5,459,079) | &nbsp;&nbsp; 6903049 |
| **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** |
| **Money Market Funds-9.82%** | **Money Market Funds-9.82%** | **Money Market Funds-9.82%** |
| Invesco Private Government Fund, 4.00%<sup>(d)(e)(f)</sup> | 190225 | &nbsp;&nbsp; 190225 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Money Market Funds-(continued)** | **Money Market Funds-(continued)** | **Money Market Funds-(continued)** |
| Invesco Private Prime Fund, 4.12%<sup>(d)(e)(f)</sup> | 487346 | &nbsp;&nbsp; $487492 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $677,717) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $677,717) | &nbsp;&nbsp; 677717 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.79% <br>(Cost $6,136,796) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.79% <br>(Cost $6,136,796) | &nbsp;&nbsp; 7580766 |
| OTHER ASSETS LESS LIABILITIES-(9.79)% | OTHER ASSETS LESS LIABILITIES-(9.79)% | &nbsp;&nbsp; (675744)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $6905022 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt <br> Rts. -Rights

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2025. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the three months ended November 30, 2025.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $277 | &nbsp;&nbsp;&nbsp; $39571 | &nbsp;&nbsp;&nbsp; $(35158)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $4690 | &nbsp;&nbsp;&nbsp; $46 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 218042 | &nbsp;&nbsp;&nbsp; 1187025 | &nbsp;&nbsp;&nbsp; (1214842)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 190225 | &nbsp;&nbsp;&nbsp; 2,299<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime <br> Fund<br>| &nbsp;&nbsp;&nbsp; 567413 | &nbsp;&nbsp;&nbsp; 2587287 | &nbsp;&nbsp;&nbsp; (2667207)<br>| &nbsp;&nbsp;&nbsp; (41)<br>| &nbsp;&nbsp;&nbsp; 40 | &nbsp;&nbsp;&nbsp; 487492 | &nbsp;&nbsp;&nbsp; 6,063<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $785732 | &nbsp;&nbsp;&nbsp; $3813883 | &nbsp;&nbsp;&nbsp; $(3917207)<br>| &nbsp;&nbsp;&nbsp; $(41)<br>| &nbsp;&nbsp;&nbsp; $40 | &nbsp;&nbsp;&nbsp; $682407 | &nbsp;&nbsp;&nbsp; $8408 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2025. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco NASDAQ 100 ETF (QQQM)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.83%** | **Common Stocks & Other Equity Interests-99.83%** | **Common Stocks & Other Equity Interests-99.83%** |
| **Communication Services-15.73%** | **Communication Services-15.73%** | **Communication Services-15.73%** |
| Alphabet, Inc., Class A | 8602310 | &nbsp;&nbsp; $2754287616 |
| Alphabet, Inc., Class C | 8029955 | &nbsp;&nbsp; 2570549195 |
| &nbsp;&nbsp;&nbsp; Charter Communications, Inc., <br> Class A<sup>(b)(c)</sup><br>| 496726 | &nbsp;&nbsp; 99404807 |
| Comcast Corp., Class A | 13394044 | &nbsp;&nbsp; 357487034 |
| Electronic Arts, Inc. | 909916 | &nbsp;&nbsp; 183830329 |
| Meta Platforms, Inc., Class A | 3207570 | &nbsp;&nbsp; 2078344982 |
| Netflix, Inc.<sup>(b)</sup> | 15460110 | &nbsp;&nbsp; 1663198634 |
| Take-Two Interactive Software, Inc.<sup>(b)</sup> | 670690 | &nbsp;&nbsp; 165036688 |
| T-Mobile US, Inc. | 4094676 | &nbsp;&nbsp; 855828231 |
| Trade Desk, Inc. (The), Class A<sup>(b)(c)</sup> | 1621309 | &nbsp;&nbsp; 64138984 |
| Warner Bros. Discovery, Inc.<sup>(b)</sup> | 9004244 | &nbsp;&nbsp; 216101856 |
|  |  | &nbsp;&nbsp; 11008208356 |
| **Consumer Discretionary-12.82%** | **Consumer Discretionary-12.82%** | **Consumer Discretionary-12.82%** |
| Airbnb, Inc., Class A<sup>(b)</sup> | 1560614 | &nbsp;&nbsp; 182576232 |
| Amazon.com, Inc.<sup>(b)</sup> | 15771868 | &nbsp;&nbsp; 3678315055 |
| Booking Holdings, Inc. | 117810 | &nbsp;&nbsp; 578999629 |
| DoorDash, Inc., Class A<sup>(b)(c)</sup> | 1463213 | &nbsp;&nbsp; 290257563 |
| lululemon athletica, Inc.<sup>(b)</sup> | 417166 | &nbsp;&nbsp; 76833634 |
| Marriott International, Inc., Class A | 987295 | &nbsp;&nbsp; 300917643 |
| MercadoLibre, Inc. (Brazil)<sup>(b)</sup> | 184797 | &nbsp;&nbsp; 382858728 |
| O'Reilly Automotive, Inc.<sup>(b)</sup> | 3085731 | &nbsp;&nbsp; 313818843 |
| PDD Holdings, Inc., ADR (China)<sup>(b)</sup> | 2428972 | &nbsp;&nbsp; 281955070 |
| Ross Stores, Inc. | 1189373 | &nbsp;&nbsp; 209757822 |
| Starbucks Corp. | 4134315 | &nbsp;&nbsp; 360140179 |
| Tesla, Inc.<sup>(b)(c)</sup> | 5389910 | &nbsp;&nbsp; 2318577585 |
|  |  | &nbsp;&nbsp; 8975007983 |
| **Consumer Staples-4.50%** | **Consumer Staples-4.50%** | **Consumer Staples-4.50%** |
| &nbsp;&nbsp;&nbsp; Coca-Cola Europacific Partners PLC <br> (United Kingdom)<br>| 1666593 | &nbsp;&nbsp; 152809912 |
| Costco Wholesale Corp. | 1613576 | &nbsp;&nbsp; 1474146898 |
| Keurig Dr Pepper, Inc. | 4940576 | &nbsp;&nbsp; 137842071 |
| Kraft Heinz Co. (The) | 4304779 | &nbsp;&nbsp; 109814912 |
| Mondelez International, Inc., Class A | 4705795 | &nbsp;&nbsp; 270912618 |
| Monster Beverage Corp.<sup>(b)</sup> | 3551036 | &nbsp;&nbsp; 266292190 |
| PepsiCo, Inc. | 4979068 | &nbsp;&nbsp; 740586574 |
|  |  | &nbsp;&nbsp; 3152405175 |
| **Energy-0.49%** | **Energy-0.49%** | **Energy-0.49%** |
| Baker Hughes Co., Class A<sup>(c)</sup> | 3585778 | &nbsp;&nbsp; 180006056 |
| Diamondback Energy, Inc. | 1052670 | &nbsp;&nbsp; 160626915 |
|  |  | &nbsp;&nbsp; 340632971 |
| **Financials-0.31%** | **Financials-0.31%** | **Financials-0.31%** |
| PayPal Holdings, Inc. | 3474869 | &nbsp;&nbsp; 217839538 |
| **Health Care-4.90%** | **Health Care-4.90%** | **Health Care-4.90%** |
| Amgen, Inc. | 1957831 | &nbsp;&nbsp; 676352297 |
| &nbsp;&nbsp;&nbsp; AstraZeneca PLC, ADR (United <br> Kingdom)<sup>(c)</sup><br>| 2136647 | &nbsp;&nbsp; 198109910 |
| Biogen, Inc.<sup>(b)(c)</sup> | 533019 | &nbsp;&nbsp; 97057430 |
| DexCom, Inc.<sup>(b)</sup> | 1426599 | &nbsp;&nbsp; 90546239 |
| GE HealthCare Technologies, Inc.<sup>(c)</sup> | 1660249 | &nbsp;&nbsp; 132803317 |
| Gilead Sciences, Inc. | 4512553 | &nbsp;&nbsp; 567859670 |
| IDEXX Laboratories, Inc.<sup>(b)</sup> | 291534 | &nbsp;&nbsp; 219490118 |
| Intuitive Surgical, Inc.<sup>(b)</sup> | 1304250 | &nbsp;&nbsp; 747961290 |
| Regeneron Pharmaceuticals, Inc. | 378960 | &nbsp;&nbsp; 295660802 |
| Vertex Pharmaceuticals, Inc.<sup>(b)</sup> | 932494 | &nbsp;&nbsp; 404338723 |
|  |  | &nbsp;&nbsp; 3430179796 |
| **Industrials-3.69%** | **Industrials-3.69%** | **Industrials-3.69%** |
| Automatic Data Processing, Inc. | 1473287 | &nbsp;&nbsp; 376130171 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Axon Enterprise, Inc.<sup>(b)</sup> | 285318 | &nbsp;&nbsp; $154111665 |
| Cintas Corp. | 1465416 | &nbsp;&nbsp; 272596684 |
| Copart, Inc.<sup>(b)</sup> | 3516641 | &nbsp;&nbsp; 137078666 |
| CSX Corp. | 6780277 | &nbsp;&nbsp; 239750595 |
| Fastenal Co. | 4173868 | &nbsp;&nbsp; 168624267 |
| Honeywell International, Inc. | 2309027 | &nbsp;&nbsp; 443771899 |
| Old Dominion Freight Line, Inc. | 764631 | &nbsp;&nbsp; 103446928 |
| PACCAR, Inc. | 1909985 | &nbsp;&nbsp; 201350619 |
| Paychex, Inc.<sup>(c)</sup> | 1308239 | &nbsp;&nbsp; 146117214 |
| Thomson Reuters Corp. (Canada)<sup>(c)</sup> | 1639270 | &nbsp;&nbsp; 222006336 |
| Verisk Analytics, Inc. | 508378 | &nbsp;&nbsp; 114420636 |
|  |  | &nbsp;&nbsp; 2579405680 |
| **Information Technology-54.81%** | **Information Technology-54.81%** | **Information Technology-54.81%** |
| Adobe, Inc.<sup>(b)</sup> | 1542693 | &nbsp;&nbsp; 493862310 |
| Advanced Micro Devices, Inc.<sup>(b)</sup> | 5904348 | &nbsp;&nbsp; 1284372820 |
| Analog Devices, Inc. | 1789127 | &nbsp;&nbsp; 474726958 |
| Apple, Inc. | 21946951 | &nbsp;&nbsp; 6119907286 |
| Applied Materials, Inc. | 2897914 | &nbsp;&nbsp; 730998807 |
| AppLovin Corp., Class A<sup>(b)</sup> | 1118976 | &nbsp;&nbsp; 670803732 |
| ARM Holdings PLC, ADR<sup>(b)(c)</sup> | 496693 | &nbsp;&nbsp; 67331703 |
| &nbsp;&nbsp;&nbsp; ASML Holding N.V., New York Shares <br> (Netherlands)<br>| 308035 | &nbsp;&nbsp; 326517100 |
| Atlassian Corp., Class A<sup>(b)</sup> | 604753 | &nbsp;&nbsp; 90422669 |
| Autodesk, Inc.<sup>(b)</sup> | 778132 | &nbsp;&nbsp; 236038561 |
| Broadcom, Inc. | 11504425 | &nbsp;&nbsp; 4635823098 |
| Cadence Design Systems, Inc.<sup>(b)</sup> | 990981 | &nbsp;&nbsp; 309027515 |
| CDW Corp. | 476481 | &nbsp;&nbsp; 68718090 |
| Cisco Systems, Inc. | 14407021 | &nbsp;&nbsp; 1108476196 |
| &nbsp;&nbsp;&nbsp; Cognizant Technology Solutions Corp., <br> Class A<sup>(c)</sup><br>| 1776580 | &nbsp;&nbsp; 138058032 |
| CrowdStrike Holdings, Inc., Class A<sup>(b)</sup> | 912587 | &nbsp;&nbsp; 464652797 |
| Datadog, Inc., Class A<sup>(b)(c)</sup> | 1175802 | &nbsp;&nbsp; 188140078 |
| Fortinet, Inc.<sup>(b)(c)</sup> | 2787105 | &nbsp;&nbsp; 226117829 |
| GLOBALFOUNDRIES, Inc.<sup>(b)(c)</sup> | 2018636 | &nbsp;&nbsp; 72347914 |
| Intel Corp.<sup>(b)</sup> | 15918960 | &nbsp;&nbsp; 645673018 |
| Intuit, Inc. | 1014569 | &nbsp;&nbsp; 643317912 |
| KLA Corp. | 479697 | &nbsp;&nbsp; 563869433 |
| Lam Research Corp. | 4603153 | &nbsp;&nbsp; 718091868 |
| Marvell Technology, Inc. | 3135303 | &nbsp;&nbsp; 280296088 |
| Microchip Technology, Inc. | 1962538 | &nbsp;&nbsp; 105152786 |
| Micron Technology, Inc.<sup>(c)</sup> | 4071788 | &nbsp;&nbsp; 962896426 |
| Microsoft Corp. | 10992537 | &nbsp;&nbsp; 5408438129 |
| NVIDIA Corp. | 35936870 | &nbsp;&nbsp; 6360825990 |
| NXP Semiconductors N.V. (Netherlands) | 916728 | &nbsp;&nbsp; 178706956 |
| ON Semiconductor Corp.<sup>(b)(c)</sup> | 1487618 | &nbsp;&nbsp; 74737928 |
| Palantir Technologies, Inc., Class A<sup>(b)</sup> | 8274150 | &nbsp;&nbsp; 1393780567 |
| Palo Alto Networks, Inc.<sup>(b)(c)</sup> | 2432940 | &nbsp;&nbsp; 462574882 |
| QUALCOMM, Inc. | 3924287 | &nbsp;&nbsp; 659633402 |
| Roper Technologies, Inc. | 391258 | &nbsp;&nbsp; 174587145 |
| Shopify, Inc., Class A (Canada)<sup>(b)</sup> | 4438750 | &nbsp;&nbsp; 704163300 |
| Strategy, Inc., Class A<sup>(b)(c)</sup> | 959853 | &nbsp;&nbsp; 170066755 |
| Synopsys, Inc.<sup>(b)</sup> | 673233 | &nbsp;&nbsp; 281418222 |
| Texas Instruments, Inc. | 3306374 | &nbsp;&nbsp; 556363553 |
| Workday, Inc., Class A<sup>(b)</sup> | 789439 | &nbsp;&nbsp; 170218837 |
| Zscaler, Inc.<sup>(b)(c)</sup> | 566552 | &nbsp;&nbsp; 142487828 |
|  |  | &nbsp;&nbsp; 38363644520 |
| **Materials-1.00%** | **Materials-1.00%** | **Materials-1.00%** |
| Linde PLC | 1705337 | &nbsp;&nbsp; 699733878 |
| **Real Estate-0.15%** | **Real Estate-0.15%** | **Real Estate-0.15%** |
| CoStar Group, Inc.<sup>(b)(c)</sup> | 1540730 | &nbsp;&nbsp; 106002224 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ 100 ETF (QQQM)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Utilities-1.43%** | **Utilities-1.43%** | **Utilities-1.43%** |
| American Electric Power Co., Inc.<sup>(c)</sup> | 1945092 | &nbsp;&nbsp; $240744037 |
| Constellation Energy Corp.<sup>(c)</sup> | 1136058 | &nbsp;&nbsp; 413934093 |
| Exelon Corp.<sup>(c)</sup> | 3673362 | &nbsp;&nbsp; 173088817 |
| Xcel Energy, Inc.<sup>(c)</sup> | 2150808 | &nbsp;&nbsp; 176602845 |
|  |  | &nbsp;&nbsp; 1004369792 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $55,484,045,559) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $55,484,045,559) | &nbsp;&nbsp; 69877429913 |
| **Money Market Funds-0.09%** | **Money Market Funds-0.09%** | **Money Market Funds-0.09%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.91%<sup>(d)(e)</sup> <br>(Cost $58,755,427)<br>| 58755427 | &nbsp;&nbsp; 58755427 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.92% <br>(Cost $55,542,800,986) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.92% <br>(Cost $55,542,800,986) | &nbsp;&nbsp; 69936185340 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** |
| **Money Market Funds-0.94%** | **Money Market Funds-0.94%** | **Money Market Funds-0.94%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 4.00%<sup>(d)(e)(f)</sup><br>| 182817171 | &nbsp;&nbsp; $182817171 |
| &nbsp;&nbsp;&nbsp; Invesco Private Prime Fund, <br> 4.12%<sup>(d)(e)(f)</sup><br>| 476626691 | &nbsp;&nbsp; 476769679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $659,586,850) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $659,586,850) | &nbsp;&nbsp; 659586850 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-100.86% <br>(Cost $56,202,387,836) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-100.86% <br>(Cost $56,202,387,836) | &nbsp;&nbsp; 70595772190 |
| OTHER ASSETS LESS LIABILITIES-(0.86)% | OTHER ASSETS LESS LIABILITIES-(0.86)% | &nbsp;&nbsp; (601723420)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $69994048770 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2025. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the three months ended November 30, 2025.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in** <br> **Affiliated** <br> **Money Market** <br> **Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco <br> Government & <br> Agency <br> Portfolio, <br> Institutional <br> Class<br>| &nbsp;&nbsp;&nbsp; $47009174 | &nbsp;&nbsp;&nbsp; $180678264 | &nbsp;&nbsp;&nbsp; $(168932011)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $58755427 | &nbsp;&nbsp;&nbsp; $675866 |
| **Investments** <br> **Purchased with** <br> **Cash Collateral** <br> **from Securities** <br> **on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government <br> Fund<br>| &nbsp;&nbsp;&nbsp; 255981103 | &nbsp;&nbsp;&nbsp; 1189543119 | &nbsp;&nbsp;&nbsp; (1262707051)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 182817171 | &nbsp;&nbsp;&nbsp; 1,902,238<br> \*<br>|
| &nbsp;&nbsp; Invesco Private <br> Prime Fund<br>| &nbsp;&nbsp;&nbsp; 689509854 | &nbsp;&nbsp;&nbsp; 1960186691 | &nbsp;&nbsp;&nbsp; (2172946630)<br>| &nbsp;&nbsp;&nbsp; (43120)<br>| &nbsp;&nbsp;&nbsp; 62884 | &nbsp;&nbsp;&nbsp; 476769679 | &nbsp;&nbsp;&nbsp; 5,205,880<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $992500131 | &nbsp;&nbsp;&nbsp; $3330408074 | &nbsp;&nbsp;&nbsp; $(3604585692)<br>| &nbsp;&nbsp;&nbsp; $(43120)<br>| &nbsp;&nbsp;&nbsp; $62884 | &nbsp;&nbsp;&nbsp; $718342277 | &nbsp;&nbsp;&nbsp; $7783984 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2025. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ 100 ETF (QQQM)—(continued)**

November 30, 2025

*(Unaudited)*

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Open Futures Contracts**<sup>(a)</sup>  | **Open Futures Contracts**<sup>(a)</sup>  | **Open Futures Contracts**<sup>(a)</sup>  | **Open Futures Contracts**<sup>(a)</sup>  | **Open Futures Contracts**<sup>(a)</sup>  | **Open Futures Contracts**<sup>(a)</sup>  |
| **Long Futures Contracts** | **Number of**<br> **Contracts**<br>| **Expiration**<br> **Month**<br>| **Notional**<br> **Value**<br>| **Value** | **Unrealized**<br> **Appreciation**<br>|
| **Equity Risk** |  |  |  |  |  |
| &nbsp;&nbsp; CME E-Mini NASDAQ 100 Index Future | &nbsp;&nbsp;&nbsp; 160 | December-2025 | &nbsp;&nbsp;&nbsp; $81542400 | &nbsp;&nbsp;&nbsp; $3935157 | &nbsp;&nbsp;&nbsp; $3935157 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Futures contracts collateralized by $29,154,394 cash held with Morgan Stanley & Co. LLC, the futures commission merchant.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco NASDAQ Future Gen 200 ETF (QQQS)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.54%** | **Common Stocks & Other Equity Interests-99.54%** | **Common Stocks & Other Equity Interests-99.54%** |
| **Communication Services-3.37%** | **Communication Services-3.37%** | **Communication Services-3.37%** |
| Bandwidth, Inc., Class A<sup>(b)</sup> | 3591 | &nbsp;&nbsp; $51136 |
| EchoStar Corp., Class A<sup>(b)(c)</sup> | 868 | &nbsp;&nbsp; 63616 |
| Gogo, Inc.<sup>(b)(c)</sup> | 4908 | &nbsp;&nbsp; 35092 |
| iHeartMedia, Inc., Class A<sup>(b)</sup> | 25281 | &nbsp;&nbsp; 99354 |
| iQIYI, Inc., ADR (China)<sup>(b)(c)</sup> | 20321 | &nbsp;&nbsp; 44503 |
| JOYY, Inc., ADR (China) | 996 | &nbsp;&nbsp; 62867 |
| Roku, Inc., Class A<sup>(b)</sup> | 558 | &nbsp;&nbsp; 54009 |
|  |  | &nbsp;&nbsp; 410577 |
| **Consumer Discretionary-6.39%** | **Consumer Discretionary-6.39%** | **Consumer Discretionary-6.39%** |
| BRP, Inc. | 855 | &nbsp;&nbsp; 59089 |
| Fox Factory Holding Corp.<sup>(b)</sup> | 1861 | &nbsp;&nbsp; 27524 |
| Garrett Motion, Inc. (Switzerland) | 4145 | &nbsp;&nbsp; 68517 |
| Gentex Corp. | 1922 | &nbsp;&nbsp; 43879 |
| Gentherm, Inc.<sup>(b)</sup> | 1465 | &nbsp;&nbsp; 52257 |
| Goodyear Tire & Rubber Co. (The)<sup>(b)</sup> | 6350 | &nbsp;&nbsp; 54991 |
| Helen of Troy Ltd.<sup>(b)(c)</sup> | 2195 | &nbsp;&nbsp; 41595 |
| Johnson Outdoors, Inc., Class A | 1335 | &nbsp;&nbsp; 54722 |
| Lovesac Co. (The)<sup>(b)(c)</sup> | 2813 | &nbsp;&nbsp; 40367 |
| MasterCraft Boat Holdings, Inc.<sup>(b)</sup> | 2454 | &nbsp;&nbsp; 45350 |
| Matthews International Corp., Class A | 2192 | &nbsp;&nbsp; 53792 |
| Newell Brands, Inc. | 9096 | &nbsp;&nbsp; 33200 |
| Sleep Number Corp.<sup>(b)(c)</sup> | 5119 | &nbsp;&nbsp; 26107 |
| Sonos, Inc.<sup>(b)</sup> | 3854 | &nbsp;&nbsp; 71530 |
| Stitch Fix, Inc., Class A<sup>(b)(c)</sup> | 10176 | &nbsp;&nbsp; 43248 |
| Strattec Security Corp.<sup>(b)</sup> | 817 | &nbsp;&nbsp; 61275 |
|  |  | &nbsp;&nbsp; 777443 |
| **Consumer Staples-0.41%** | **Consumer Staples-0.41%** | **Consumer Staples-0.41%** |
| Central Garden & Pet Co.<sup>(b)</sup> | 1477 | &nbsp;&nbsp; 50454 |
| **Energy-0.96%** | **Energy-0.96%** | **Energy-0.96%** |
| DMC Global, Inc.<sup>(b)</sup> | 8045 | &nbsp;&nbsp; 49959 |
| Gevo, Inc.<sup>(b)</sup> | 31143 | &nbsp;&nbsp; 66646 |
|  |  | &nbsp;&nbsp; 116605 |
| **Health Care-52.07%** | **Health Care-52.07%** | **Health Care-52.07%** |
| 10X Genomics, Inc., Class A<sup>(b)(c)</sup> | 3844 | &nbsp;&nbsp; 72306 |
| Aclaris Therapeutics, Inc.<sup>(b)</sup> | 27901 | &nbsp;&nbsp; 78960 |
| Adaptive Biotechnologies Corp.<sup>(b)</sup> | 4086 | &nbsp;&nbsp; 80331 |
| Agios Pharmaceuticals, Inc.<sup>(b)</sup> | 1429 | &nbsp;&nbsp; 41727 |
| Akebia Therapeutics, Inc.<sup>(b)</sup> | 17148 | &nbsp;&nbsp; 27094 |
| Aldeyra Therapeutics, Inc.<sup>(b)(c)</sup> | 9218 | &nbsp;&nbsp; 50515 |
| Alector, Inc.<sup>(b)</sup> | 22927 | &nbsp;&nbsp; 30493 |
| Allogene Therapeutics, Inc.<sup>(b)(c)</sup> | 47702 | &nbsp;&nbsp; 69645 |
| Alphatec Holdings, Inc.<sup>(b)</sup> | 3387 | &nbsp;&nbsp; 76377 |
| Altimmune, Inc.<sup>(b)</sup> | 14060 | &nbsp;&nbsp; 73956 |
| Amicus Therapeutics, Inc.<sup>(b)</sup> | 7095 | &nbsp;&nbsp; 70453 |
| AngioDynamics, Inc.<sup>(b)</sup> | 5248 | &nbsp;&nbsp; 65075 |
| Anika Therapeutics, Inc.<sup>(b)</sup> | 5740 | &nbsp;&nbsp; 56711 |
| Aquestive Therapeutics, Inc.<sup>(b)(c)</sup> | 14283 | &nbsp;&nbsp; 88412 |
| Arbutus Biopharma Corp.<sup>(b)</sup> | 14529 | &nbsp;&nbsp; 64073 |
| Ardelyx, Inc.<sup>(b)</sup> | 8467 | &nbsp;&nbsp; 49109 |
| Arrowhead Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 2444 | &nbsp;&nbsp; 128799 |
| Arvinas, Inc.<sup>(b)</sup> | 6966 | &nbsp;&nbsp; 87667 |
| Atai Beckley N.V. (Germany)<sup>(b)</sup> | 11771 | &nbsp;&nbsp; 45789 |
| AtriCure, Inc.<sup>(b)(c)</sup> | 1458 | &nbsp;&nbsp; 52663 |
| &nbsp;&nbsp;&nbsp; Autolus Therapeutics PLC, ADR (United <br> Kingdom)<sup>(b)(c)</sup><br>| 35898 | &nbsp;&nbsp; 50616 |
| Axogen, Inc.<sup>(b)</sup> | 3336 | &nbsp;&nbsp; 95576 |
| Azenta, Inc.<sup>(b)(c)</sup> | 1764 | &nbsp;&nbsp; 62728 |
| &nbsp;&nbsp;&nbsp; Bicycle Therapeutics PLC, ADR (United <br> Kingdom)<sup>(b)</sup><br>| 7294 | &nbsp;&nbsp; 54559 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| BioCryst Pharmaceuticals, Inc.<sup>(b)</sup> | 6479 | &nbsp;&nbsp; $46519 |
| Bruker Corp. | 1585 | &nbsp;&nbsp; 77364 |
| &nbsp;&nbsp;&nbsp; Cartesian Therapeutics, Inc., Rts., expiring <br> 12/31/2049<sup>(b)(d)</sup><br>| 27325 | &nbsp;&nbsp; 3728 |
| Cerus Corp.<sup>(b)</sup> | 41147 | &nbsp;&nbsp; 72419 |
| ClearPoint Neuro, Inc.<sup>(b)(c)</sup> | 5133 | &nbsp;&nbsp; 74223 |
| Codexis, Inc.<sup>(b)</sup> | 19726 | &nbsp;&nbsp; 34126 |
| Corvus Pharmaceuticals, Inc.<sup>(b)</sup> | 9381 | &nbsp;&nbsp; 86024 |
| CryoPort, Inc.<sup>(b)</sup> | 6081 | &nbsp;&nbsp; 58499 |
| CytomX Therapeutics, Inc.<sup>(b)</sup> | 26396 | &nbsp;&nbsp; 112975 |
| DENTSPLY SIRONA, Inc. | 3767 | &nbsp;&nbsp; 42718 |
| Editas Medicine, Inc.<sup>(b)</sup> | 20966 | &nbsp;&nbsp; 50528 |
| Embecta Corp. | 3717 | &nbsp;&nbsp; 47410 |
| Enanta Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 6411 | &nbsp;&nbsp; 90523 |
| Esperion Therapeutics, Inc.<sup>(b)(c)</sup> | 24256 | &nbsp;&nbsp; 97266 |
| Exagen, Inc.<sup>(b)</sup> | 5461 | &nbsp;&nbsp; 43142 |
| Fate Therapeutics, Inc.<sup>(b)</sup> | 51772 | &nbsp;&nbsp; 59020 |
| Geron Corp.<sup>(b)</sup> | 38461 | &nbsp;&nbsp; 45384 |
| Heron Therapeutics, Inc.<sup>(b)(c)</sup> | 39887 | &nbsp;&nbsp; 46269 |
| ICU Medical, Inc.<sup>(b)</sup> | 422 | &nbsp;&nbsp; 62642 |
| Innoviva, Inc.<sup>(b)</sup> | 2636 | &nbsp;&nbsp; 57280 |
| Inogen, Inc.<sup>(b)</sup> | 6739 | &nbsp;&nbsp; 47712 |
| Integra LifeSciences Holdings Corp.<sup>(b)</sup> | 3560 | &nbsp;&nbsp; 46707 |
| Ionis Pharmaceuticals, Inc.<sup>(b)</sup> | 1263 | &nbsp;&nbsp; 104488 |
| Iovance Biotherapeutics, Inc.<sup>(b)</sup> | 24146 | &nbsp;&nbsp; 59641 |
| KalVista Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 4002 | &nbsp;&nbsp; 57909 |
| Kura Oncology, Inc.<sup>(b)</sup> | 6816 | &nbsp;&nbsp; 82746 |
| Lexicon Pharmaceuticals, Inc.<sup>(b)</sup> | 48989 | &nbsp;&nbsp; 70054 |
| Ligand Pharmaceuticals, Inc.<sup>(b)</sup> | 333 | &nbsp;&nbsp; 67659 |
| LivaNova PLC<sup>(b)</sup> | 956 | &nbsp;&nbsp; 61002 |
| MannKind Corp.<sup>(b)</sup> | 11736 | &nbsp;&nbsp; 62788 |
| Masimo Corp.<sup>(b)</sup> | 385 | &nbsp;&nbsp; 54835 |
| MaxCyte, Inc.<sup>(b)</sup> | 38775 | &nbsp;&nbsp; 68244 |
| MediWound Ltd. (Israel)<sup>(b)</sup> | 3226 | &nbsp;&nbsp; 57810 |
| Merit Medical Systems, Inc.<sup>(b)</sup> | 595 | &nbsp;&nbsp; 51521 |
| MiMedx Group, Inc.<sup>(b)</sup> | 7584 | &nbsp;&nbsp; 52178 |
| Myriad Genetics, Inc.<sup>(b)</sup> | 8451 | &nbsp;&nbsp; 64481 |
| Nektar Therapeutics<sup>(b)</sup> | 1803 | &nbsp;&nbsp; 117574 |
| Neogen Corp.<sup>(b)</sup> | 9366 | &nbsp;&nbsp; 56009 |
| Neuronetics, Inc.<sup>(b)</sup> | 16170 | &nbsp;&nbsp; 24093 |
| Ocugen, Inc.<sup>(b)(c)</sup> | 52807 | &nbsp;&nbsp; 65481 |
| Omeros Corp.<sup>(b)(c)</sup> | 12944 | &nbsp;&nbsp; 125427 |
| OmniAb, Inc., Rts., expiring 11/02/2027<sup>(b)(d)</sup> | 83 | &nbsp;&nbsp; 0 |
| OmniAb, Inc., Rts., expiring 11/02/2027<sup>(b)(d)</sup> | 83 | &nbsp;&nbsp; 0 |
| Omnicell, Inc.<sup>(b)</sup> | 1652 | &nbsp;&nbsp; 60314 |
| OPKO Health, Inc.<sup>(b)(c)</sup> | 38996 | &nbsp;&nbsp; 53034 |
| OraSure Technologies, Inc.<sup>(b)</sup> | 16266 | &nbsp;&nbsp; 38713 |
| Orthofix Medical, Inc.<sup>(b)</sup> | 3596 | &nbsp;&nbsp; 57860 |
| OrthoPediatrics Corp.<sup>(b)(c)</sup> | 2521 | &nbsp;&nbsp; 46613 |
| Pacific Biosciences of California, Inc.<sup>(b)</sup> | 41106 | &nbsp;&nbsp; 95366 |
| Pacira BioSciences, Inc.<sup>(b)</sup> | 2020 | &nbsp;&nbsp; 47611 |
| Personalis, Inc.<sup>(b)</sup> | 11012 | &nbsp;&nbsp; 118159 |
| Phibro Animal Health Corp., Class A | 1453 | &nbsp;&nbsp; 60852 |
| Pro-Dex, Inc.<sup>(b)(c)</sup> | 1150 | &nbsp;&nbsp; 41906 |
| Prothena Corp. PLC (Ireland)<sup>(b)</sup> | 6567 | &nbsp;&nbsp; 70595 |
| PTC Therapeutics, Inc.<sup>(b)</sup> | 1092 | &nbsp;&nbsp; 93901 |
| Quanterix Corp.<sup>(b)</sup> | 11835 | &nbsp;&nbsp; 85922 |
| Sangamo Therapeutics, Inc.<sup>(b)</sup> | 103605 | &nbsp;&nbsp; 47762 |
| Scilex Holding Co., Class C (Singapore)<sup>(b)</sup> | 72 | &nbsp;&nbsp; 1466 |
| SI-BONE, Inc.<sup>(b)</sup> | 3230 | &nbsp;&nbsp; 62856 |
| SIGA Technologies, Inc. | 6416 | &nbsp;&nbsp; 38881 |
| Spero Therapeutics, Inc.<sup>(b)</sup> | 26014 | &nbsp;&nbsp; 62434 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ Future Gen 200 ETF (QQQS)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| Standard BioTools, Inc.<sup>(b)</sup> | 42752 | &nbsp;&nbsp; $64128 |
| Supernus Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 1193 | &nbsp;&nbsp; 54389 |
| Tactile Systems Technology, Inc.<sup>(b)</sup> | 4046 | &nbsp;&nbsp; 104023 |
| Tandem Diabetes Care, Inc.<sup>(b)(c)</sup> | 4304 | &nbsp;&nbsp; 90427 |
| Theravance Biopharma, Inc.<sup>(b)(c)</sup> | 3880 | &nbsp;&nbsp; 78764 |
| uniQure N.V. (Netherlands)<sup>(b)</sup> | 3298 | &nbsp;&nbsp; 90728 |
| Vanda Pharmaceuticals, Inc.<sup>(b)(c)</sup> | 11384 | &nbsp;&nbsp; 61018 |
| Varex Imaging Corp.<sup>(b)</sup> | 4662 | &nbsp;&nbsp; 53939 |
| Ventyx Biosciences, Inc.<sup>(b)(c)</sup> | 22437 | &nbsp;&nbsp; 224370 |
| Vir Biotechnology, Inc.<sup>(b)(c)</sup> | 10914 | &nbsp;&nbsp; 70068 |
| Voyager Therapeutics, Inc.<sup>(b)(c)</sup> | 16032 | &nbsp;&nbsp; 65571 |
| Xencor, Inc.<sup>(b)(c)</sup> | 6623 | &nbsp;&nbsp; 114710 |
|  |  | &nbsp;&nbsp; 6336432 |
| **Industrials-5.95%** | **Industrials-5.95%** | **Industrials-5.95%** |
| AeroVironment, Inc.<sup>(b)</sup> | 223 | &nbsp;&nbsp; 62320 |
| Allient, Inc. | 1188 | &nbsp;&nbsp; 63986 |
| American Superconductor Corp.<sup>(b)</sup> | 1081 | &nbsp;&nbsp; 33608 |
| Ballard Power Systems, Inc. (Canada)<sup>(b)</sup> | 26658 | &nbsp;&nbsp; 75709 |
| Columbus McKinnon Corp. | 3596 | &nbsp;&nbsp; 59118 |
| Conduent, Inc.<sup>(b)</sup> | 19293 | &nbsp;&nbsp; 37428 |
| Energy Recovery, Inc.<sup>(b)</sup> | 3791 | &nbsp;&nbsp; 54780 |
| FreightCar America, Inc.<sup>(b)</sup> | 6301 | &nbsp;&nbsp; 51542 |
| Innovative Solutions and Support, Inc.<sup>(b)(c)</sup> | 4159 | &nbsp;&nbsp; 40509 |
| LSI Industries, Inc. | 2348 | &nbsp;&nbsp; 42945 |
| Lyft, Inc., Class A<sup>(b)</sup> | 3320 | &nbsp;&nbsp; 69820 |
| MillerKnoll, Inc. | 2553 | &nbsp;&nbsp; 40414 |
| Stratasys Ltd.<sup>(b)(c)</sup> | 5055 | &nbsp;&nbsp; 44433 |
| TTEC Holdings, Inc.<sup>(b)(c)</sup> | 14208 | &nbsp;&nbsp; 47739 |
|  |  | &nbsp;&nbsp; 724351 |
| **Information Technology-29.80%** | **Information Technology-29.80%** | **Information Technology-29.80%** |
| 8x8, Inc.<sup>(b)</sup> | 27186 | &nbsp;&nbsp; 52741 |
| Advanced Energy Industries, Inc. | 360 | &nbsp;&nbsp; 76028 |
| Aehr Test Systems<sup>(b)(c)</sup> | 2161 | &nbsp;&nbsp; 49638 |
| Agora, Inc., ADR (China)<sup>(b)</sup> | 15599 | &nbsp;&nbsp; 56312 |
| Allegro MicroSystems, Inc. (Japan)<sup>(b)</sup> | 1745 | &nbsp;&nbsp; 46574 |
| Allot Ltd. (Israel)<sup>(b)</sup> | 6856 | &nbsp;&nbsp; 65681 |
| Alpha & Omega Semiconductor Ltd.<sup>(b)</sup> | 1869 | &nbsp;&nbsp; 37903 |
| Amkor Technology, Inc. | 2226 | &nbsp;&nbsp; 81004 |
| Applied Optoelectronics, Inc.<sup>(b)(c)</sup> | 2215 | &nbsp;&nbsp; 59318 |
| Arbe Robotics Ltd. (Israel)<sup>(b)(c)</sup> | 41417 | &nbsp;&nbsp; 60883 |
| Atomera, Inc.<sup>(b)(c)</sup> | 16416 | &nbsp;&nbsp; 40712 |
| AudioEye, Inc.<sup>(b)</sup> | 4197 | &nbsp;&nbsp; 51875 |
| Aviat Networks, Inc.<sup>(b)</sup> | 2345 | &nbsp;&nbsp; 51848 |
| Axcelis Technologies, Inc.<sup>(b)</sup> | 673 | &nbsp;&nbsp; 55704 |
| Bel Fuse, Inc., Class B | 400 | &nbsp;&nbsp; 61612 |
| Canadian Solar, Inc. (Canada)<sup>(b)(c)</sup> | 5506 | &nbsp;&nbsp; 149488 |
| Cirrus Logic, Inc.<sup>(b)</sup> | 472 | &nbsp;&nbsp; 56800 |
| Cognex Corp. | 1225 | &nbsp;&nbsp; 46673 |
| Cohu, Inc.<sup>(b)(c)</sup> | 2707 | &nbsp;&nbsp; 65834 |
| CommScope Holding Co., Inc.<sup>(b)</sup> | 3356 | &nbsp;&nbsp; 66247 |
| Commvault Systems, Inc.<sup>(b)</sup> | 289 | &nbsp;&nbsp; 35692 |
| Digimarc Corp.<sup>(b)(c)</sup> | 6218 | &nbsp;&nbsp; 49806 |
| Diodes, Inc.<sup>(b)</sup> | 990 | &nbsp;&nbsp; 45748 |
| Dropbox, Inc., Class A<sup>(b)</sup> | 1853 | &nbsp;&nbsp; 55368 |
| Extreme Networks, Inc.<sup>(b)</sup> | 2519 | &nbsp;&nbsp; 44083 |
| Gilat Satellite Networks Ltd. (Israel)<sup>(b)(c)</sup> | 5722 | &nbsp;&nbsp; 66604 |
| Himax Technologies, Inc., ADR (Taiwan) | 6613 | &nbsp;&nbsp; 49994 |
| Immersion Corp.<sup>(c)</sup> | 7623 | &nbsp;&nbsp; 54200 |
| Innoviz Technologies Ltd. (Israel)<sup>(b)(c)</sup> | 32267 | &nbsp;&nbsp; 41302 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Information Technology-(continued)** | **Information Technology-(continued)** | **Information Technology-(continued)** |
| InterDigital, Inc. | 198 | &nbsp;&nbsp; $70835 |
| IPG Photonics Corp.<sup>(b)</sup> | 657 | &nbsp;&nbsp; 52323 |
| Itron, Inc.<sup>(b)</sup> | 438 | &nbsp;&nbsp; 43380 |
| Kopin Corp.<sup>(b)(c)</sup> | 25658 | &nbsp;&nbsp; 62606 |
| Kulicke & Soffa Industries, Inc. (Singapore) | 1437 | &nbsp;&nbsp; 64823 |
| Lattice Semiconductor Corp.<sup>(b)</sup> | 811 | &nbsp;&nbsp; 56940 |
| Littelfuse, Inc. | 207 | &nbsp;&nbsp; 52996 |
| Lumentum Holdings, Inc.<sup>(b)</sup> | 405 | &nbsp;&nbsp; 131690 |
| MaxLinear, Inc.<sup>(b)</sup> | 3427 | &nbsp;&nbsp; 53358 |
| MicroVision, Inc.<sup>(b)(c)</sup> | 46867 | &nbsp;&nbsp; 44144 |
| Mitek Systems, Inc.<sup>(b)</sup> | 5292 | &nbsp;&nbsp; 46887 |
| MKS, Inc. | 520 | &nbsp;&nbsp; 81323 |
| Navitas Semiconductor Corp.<sup>(b)(c)</sup> | 9158 | &nbsp;&nbsp; 80041 |
| NETGEAR, Inc.<sup>(b)</sup> | 1985 | &nbsp;&nbsp; 52503 |
| nLight, Inc.<sup>(b)</sup> | 1870 | &nbsp;&nbsp; 65880 |
| Open Text Corp. (Canada) | 1621 | &nbsp;&nbsp; 54530 |
| Power Integrations, Inc. | 1194 | &nbsp;&nbsp; 40118 |
| Qorvo, Inc.<sup>(b)</sup> | 594 | &nbsp;&nbsp; 51019 |
| Rambus, Inc.<sup>(b)</sup> | 727 | &nbsp;&nbsp; 69479 |
| Rapid7, Inc.<sup>(b)</sup> | 2599 | &nbsp;&nbsp; 40752 |
| Ribbon Communications, Inc.<sup>(b)</sup> | 13197 | &nbsp;&nbsp; 37743 |
| Semtech Corp.<sup>(b)</sup> | 927 | &nbsp;&nbsp; 68746 |
| Silicon Laboratories, Inc.<sup>(b)</sup> | 401 | &nbsp;&nbsp; 51160 |
| Silicon Motion Technology Corp., ADR (Taiwan) | 676 | &nbsp;&nbsp; 60137 |
| SolarEdge Technologies, Inc.<sup>(b)</sup> | 1592 | &nbsp;&nbsp; 58156 |
| Synaptics, Inc.<sup>(b)</sup> | 771 | &nbsp;&nbsp; 52821 |
| Turtle Beach Corp.<sup>(b)(c)</sup> | 3403 | &nbsp;&nbsp; 47234 |
| Universal Display Corp. | 388 | &nbsp;&nbsp; 46145 |
| Veeco Instruments, Inc.<sup>(b)(c)</sup> | 2198 | &nbsp;&nbsp; 64248 |
| Viasat, Inc.<sup>(b)</sup> | 1668 | &nbsp;&nbsp; 57262 |
| Viavi Solutions, Inc.<sup>(b)</sup> | 4761 | &nbsp;&nbsp; 85412 |
| Vuzix Corp.<sup>(b)(c)</sup> | 25400 | &nbsp;&nbsp; 68326 |
| Xerox Holdings Corp.<sup>(c)</sup> | 13478 | &nbsp;&nbsp; 37469 |
|  |  | &nbsp;&nbsp; 3626158 |
| **Materials-0.59%** | **Materials-0.59%** | **Materials-0.59%** |
| Arq, Inc.<sup>(b)(c)</sup> | 6973 | &nbsp;&nbsp; 25940 |
| Innospec, Inc. | 612 | &nbsp;&nbsp; 45753 |
|  |  | &nbsp;&nbsp; 71693 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-99.54% <br>(Cost $10,415,201) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral from <br> securities on loan)-99.54% <br>(Cost $10,415,201) | &nbsp;&nbsp; 12113713 |
| **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** |
| **Money Market Funds-22.12%** | **Money Market Funds-22.12%** | **Money Market Funds-22.12%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 4.00%<sup>(e)(f)(g)</sup><br>| 737178 | &nbsp;&nbsp; 737178 |
| Invesco Private Prime Fund, 4.12%<sup>(e)(f)(g)</sup> | 1954742 | &nbsp;&nbsp; 1955328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $2,692,506) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $2,692,506) | &nbsp;&nbsp; 2692506 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-121.66% <br>(Cost $13,107,707) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-121.66% <br>(Cost $13,107,707) | &nbsp;&nbsp; 14806219 |
| OTHER ASSETS LESS LIABILITIES-(21.66)% | OTHER ASSETS LESS LIABILITIES-(21.66)% | &nbsp;&nbsp; (2636206)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $12170013 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ Future Gen 200 ETF (QQQS)—(continued)**

November 30, 2025

*(Unaudited)*

Investment Abbreviations: <br> ADR -American Depositary Receipt <br> Rts. -Rights

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2025. |
| <sup>(d)</sup> | Security valued using significant unobservable inputs (Level 3). See Note 1. |
| <sup>(e)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the three months ended November 30, 2025.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $3217 | &nbsp;&nbsp;&nbsp; $157633 | &nbsp;&nbsp;&nbsp; $(160850)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $107 |
| **Investments Purchased** <br> **with Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; 368246 | &nbsp;&nbsp;&nbsp; 1548270 | &nbsp;&nbsp;&nbsp; (1179338)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 737178 | &nbsp;&nbsp;&nbsp; 4,739<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime <br> Fund<br>| &nbsp;&nbsp;&nbsp; 958237 | &nbsp;&nbsp;&nbsp; 3255963 | &nbsp;&nbsp;&nbsp; (2258817)<br>| &nbsp;&nbsp;&nbsp; (60)<br>| &nbsp;&nbsp;&nbsp; 5 | &nbsp;&nbsp;&nbsp; 1955328 | &nbsp;&nbsp;&nbsp; 12,546<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $1329700 | &nbsp;&nbsp;&nbsp; $4961866 | &nbsp;&nbsp;&nbsp; $(3599005)<br>| &nbsp;&nbsp;&nbsp; $(60)<br>| &nbsp;&nbsp;&nbsp; $5 | &nbsp;&nbsp;&nbsp; $2692506 | &nbsp;&nbsp;&nbsp; $17392 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(f)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2025. <br> <sup>(g)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco NASDAQ Next Gen 100 ETF (QQQJ)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.94%** | **Common Stocks & Other Equity Interests-99.94%** | **Common Stocks & Other Equity Interests-99.94%** |
| **Communication Services-5.72%** | **Communication Services-5.72%** | **Communication Services-5.72%** |
| Baidu, Inc., ADR (China)<sup>(b)(c)</sup> | 50943 | &nbsp;&nbsp; $5954727 |
| Fox Corp., Class A<sup>(c)</sup> | 80589 | &nbsp;&nbsp; 5278579 |
| Fox Corp., Class B | 90425 | &nbsp;&nbsp; 5268161 |
| GCI Liberty, Inc., Class A<sup>(b)</sup> | 1415 | &nbsp;&nbsp; 47176 |
| GCI Liberty, Inc., Class C<sup>(b)(c)</sup> | 9457 | &nbsp;&nbsp; 315107 |
| &nbsp;&nbsp;&nbsp; GCI Liberty, Inc., Rts., expiring <br> 12/17/2025<sup>(b)</sup><br>| 4164 | &nbsp;&nbsp; 25817 |
| Liberty Broadband Corp., Class A<sup>(b)</sup> | 7027 | &nbsp;&nbsp; 325420 |
| Liberty Broadband Corp., Class C<sup>(b)(c)</sup> | 47903 | &nbsp;&nbsp; 2217430 |
| Liberty Media Corp.-Liberty Formula One<sup>(b)</sup> | 85964 | &nbsp;&nbsp; 8250825 |
| Liberty Media Corp.-Liberty Formula One<sup>(b)</sup> | 9223 | &nbsp;&nbsp; 810517 |
| Liberty Media Corp.-Liberty Live<sup>(b)(c)</sup> | 9815 | &nbsp;&nbsp; 754970 |
| &nbsp;&nbsp;&nbsp; Liberty Media Corp.-Liberty Live, <br> Series C<sup>(b)(c)</sup><br>| 24459 | &nbsp;&nbsp; 1937397 |
| NetEase, Inc., ADR (China) | 33191 | &nbsp;&nbsp; 4582018 |
| News Corp., Class A | 144470 | &nbsp;&nbsp; 3709990 |
| News Corp., Class B<sup>(c)</sup> | 72374 | &nbsp;&nbsp; 2129967 |
|  |  | &nbsp;&nbsp; 41608101 |
| **Consumer Discretionary-11.57%** | **Consumer Discretionary-11.57%** | **Consumer Discretionary-11.57%** |
| DraftKings, Inc., Class A<sup>(b)</sup> | 190520 | &nbsp;&nbsp; 6317643 |
| Duolingo, Inc.<sup>(b)</sup> | 15248 | &nbsp;&nbsp; 2918620 |
| eBay, Inc. | 175620 | &nbsp;&nbsp; 14539580 |
| Expedia Group, Inc. | 45424 | &nbsp;&nbsp; 11614463 |
| JD.com, Inc., ADR (China) | 183634 | &nbsp;&nbsp; 5477802 |
| Pool Corp.<sup>(c)</sup> | 14310 | &nbsp;&nbsp; 3485916 |
| Rivian Automotive, Inc., Class A<sup>(b)(c)</sup> | 464208 | &nbsp;&nbsp; 7826547 |
| Texas Roadhouse, Inc. | 25507 | &nbsp;&nbsp; 4470102 |
| Tractor Supply Co.<sup>(c)</sup> | 203672 | &nbsp;&nbsp; 11157152 |
| Trip.com Group Ltd., ADR (China) | 101849 | &nbsp;&nbsp; 7121282 |
| Ulta Beauty, Inc.<sup>(b)</sup> | 17222 | &nbsp;&nbsp; 9279730 |
|  |  | &nbsp;&nbsp; 84208837 |
| **Consumer Staples-4.31%** | **Consumer Staples-4.31%** | **Consumer Staples-4.31%** |
| Campbell's Co. (The)<sup>(c)</sup> | 114443 | &nbsp;&nbsp; 3488223 |
| Casey's General Stores, Inc. | 14295 | &nbsp;&nbsp; 8154726 |
| Dollar Tree, Inc.<sup>(b)(c)</sup> | 80219 | &nbsp;&nbsp; 8889067 |
| Maplebear, Inc.<sup>(b)</sup> | 101097 | &nbsp;&nbsp; 4247085 |
| Pilgrim's Pride Corp. | 91162 | &nbsp;&nbsp; 3467802 |
| Sprouts Farmers Market, Inc.<sup>(b)</sup> | 37507 | &nbsp;&nbsp; 3143462 |
|  |  | &nbsp;&nbsp; 31390365 |
| **Energy-1.53%** | **Energy-1.53%** | **Energy-1.53%** |
| Expand Energy Corp. | 91537 | &nbsp;&nbsp; 11161106 |
| **Financials-1.74%** | **Financials-1.74%** | **Financials-1.74%** |
| Affirm Holdings, Inc.<sup>(b)</sup> | 109565 | &nbsp;&nbsp; 7773637 |
| Jack Henry & Associates, Inc. | 27960 | &nbsp;&nbsp; 4878461 |
|  |  | &nbsp;&nbsp; 12652098 |
| **Health Care-23.44%** | **Health Care-23.44%** | **Health Care-23.44%** |
| Align Technology, Inc.<sup>(b)</sup> | 27815 | &nbsp;&nbsp; 4094090 |
| Alnylam Pharmaceuticals, Inc.<sup>(b)</sup> | 50355 | &nbsp;&nbsp; 22721687 |
| argenx SE, ADR (Netherlands)<sup>(b)</sup> | 11752 | &nbsp;&nbsp; 10717589 |
| BioMarin Pharmaceutical, Inc.<sup>(b)</sup> | 73679 | &nbsp;&nbsp; 4120866 |
| BioNTech SE, ADR (Germany)<sup>(b)(c)</sup> | 38632 | &nbsp;&nbsp; 3984891 |
| Bio-Techne Corp.<sup>(c)</sup> | 59688 | &nbsp;&nbsp; 3850473 |
| Cooper Cos., Inc. (The)<sup>(b)</sup> | 76319 | &nbsp;&nbsp; 5947540 |
| Hologic, Inc.<sup>(b)</sup> | 85353 | &nbsp;&nbsp; 6398914 |
| ICON PLC<sup>(b)</sup> | 29843 | &nbsp;&nbsp; 5520955 |
| Illumina, Inc.<sup>(b)(c)</sup> | 58995 | &nbsp;&nbsp; 7754893 |
| Incyte Corp.<sup>(b)</sup> | 74948 | &nbsp;&nbsp; 7829068 |
| Insmed, Inc.<sup>(b)</sup> | 81221 | &nbsp;&nbsp; 16875287 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Health Care-(continued)** | **Health Care-(continued)** | **Health Care-(continued)** |
| Insulet Corp.<sup>(b)</sup> | 27031 | &nbsp;&nbsp; $8844273 |
| Medpace Holdings, Inc.<sup>(b)</sup> | 10803 | &nbsp;&nbsp; 6400345 |
| Moderna, Inc.<sup>(b)(c)</sup> | 149298 | &nbsp;&nbsp; 3878762 |
| Natera, Inc.<sup>(b)</sup> | 52691 | &nbsp;&nbsp; 12583138 |
| Neurocrine Biosciences, Inc.<sup>(b)</sup> | 38156 | &nbsp;&nbsp; 5805817 |
| Royalty Pharma PLC, Class A<sup>(c)</sup> | 165912 | &nbsp;&nbsp; 6639798 |
| Sanofi S.A., ADR | 102973 | &nbsp;&nbsp; 5136293 |
| Sarepta Therapeutics, Inc.<sup>(b)(c)</sup> | 37502 | &nbsp;&nbsp; 800293 |
| Summit Therapeutics, Inc.<sup>(b)(c)</sup> | 285085 | &nbsp;&nbsp; 5100171 |
| United Therapeutics Corp.<sup>(b)(c)</sup> | 17367 | &nbsp;&nbsp; 8440362 |
| Vaxcyte, Inc.<sup>(b)(c)</sup> | 49814 | &nbsp;&nbsp; 2471272 |
| Viatris, Inc. | 447431 | &nbsp;&nbsp; 4783037 |
|  |  | &nbsp;&nbsp; 170699814 |
| **Industrials-12.79%** | **Industrials-12.79%** | **Industrials-12.79%** |
| AAON, Inc. | 31298 | &nbsp;&nbsp; 2925737 |
| C.H. Robinson Worldwide, Inc. | 45325 | &nbsp;&nbsp; 7200783 |
| Elbit Systems Ltd. (Israel) | 17676 | &nbsp;&nbsp; 8304008 |
| FTAI Aviation Ltd. | 39369 | &nbsp;&nbsp; 6820285 |
| Grab Holdings Ltd., Class A (Singapore)<sup>(b)</sup> | 1517706 | &nbsp;&nbsp; 8271498 |
| J.B. Hunt Transport Services, Inc. | 37160 | &nbsp;&nbsp; 6464354 |
| Lincoln Electric Holdings, Inc. | 21193 | &nbsp;&nbsp; 5074240 |
| Nordson Corp. | 21568 | &nbsp;&nbsp; 5125851 |
| Paylocity Holding Corp.<sup>(b)</sup> | 21184 | &nbsp;&nbsp; 3121039 |
| Ryanair Holdings PLC, ADR (Italy)<sup>(c)</sup> | 84687 | &nbsp;&nbsp; 5772266 |
| Saia, Inc.<sup>(b)(c)</sup> | 10214 | &nbsp;&nbsp; 2875854 |
| SS&C Technologies Holdings, Inc. | 93887 | &nbsp;&nbsp; 8068649 |
| Tetra Tech, Inc. | 100848 | &nbsp;&nbsp; 3503459 |
| United Airlines Holdings, Inc.<sup>(b)</sup> | 124410 | &nbsp;&nbsp; 12684843 |
| Woodward, Inc. | 23031 | &nbsp;&nbsp; 6909991 |
|  |  | &nbsp;&nbsp; 93122857 |
| **Information Technology-33.79%** | **Information Technology-33.79%** | **Information Technology-33.79%** |
| Akamai Technologies, Inc.<sup>(b)</sup> | 55037 | &nbsp;&nbsp; 4926912 |
| Astera Labs, Inc.<sup>(b)</sup> | 63887 | &nbsp;&nbsp; 10066675 |
| Bentley Systems, Inc., Class B | 112115 | &nbsp;&nbsp; 4704345 |
| &nbsp;&nbsp;&nbsp; Check Point Software Technologies Ltd. <br> (Israel)<sup>(b)</sup><br>| 41208 | &nbsp;&nbsp; 7696418 |
| CyberArk Software Ltd.<sup>(b)</sup> | 19000 | &nbsp;&nbsp; 8713210 |
| DocuSign, Inc.<sup>(b)</sup> | 77538 | &nbsp;&nbsp; 5377260 |
| Entegris, Inc. | 58161 | &nbsp;&nbsp; 4486540 |
| F5, Inc.<sup>(b)</sup> | 22040 | &nbsp;&nbsp; 5271086 |
| First Solar, Inc.<sup>(b)</sup> | 41168 | &nbsp;&nbsp; 11235571 |
| Flex Ltd.<sup>(b)</sup> | 144051 | &nbsp;&nbsp; 8514855 |
| Gen Digital, Inc. | 236335 | &nbsp;&nbsp; 6232154 |
| &nbsp;&nbsp;&nbsp; Logitech International S.A., Class R <br> (Switzerland)<sup>(c)</sup><br>| 56549 | &nbsp;&nbsp; 6374769 |
| Manhattan Associates, Inc.<sup>(b)</sup> | 23219 | &nbsp;&nbsp; 4096993 |
| Monday.com Ltd.<sup>(b)</sup> | 19784 | &nbsp;&nbsp; 2846126 |
| Monolithic Power Systems, Inc. | 18396 | &nbsp;&nbsp; 17074615 |
| NetApp, Inc. | 76622 | &nbsp;&nbsp; 8547950 |
| Nutanix, Inc., Class A<sup>(b)</sup> | 102882 | &nbsp;&nbsp; 4917760 |
| Okta, Inc.<sup>(b)(c)</sup> | 64666 | &nbsp;&nbsp; 5194620 |
| PTC, Inc.<sup>(b)</sup> | 46049 | &nbsp;&nbsp; 8078376 |
| Sandisk Corp.<sup>(b)</sup> | 56157 | &nbsp;&nbsp; 12538735 |
| Seagate Technology Holdings PLC | 81701 | &nbsp;&nbsp; 22605850 |
| Skyworks Solutions, Inc.<sup>(c)</sup> | 56973 | &nbsp;&nbsp; 3757369 |
| Super Micro Computer, Inc.<sup>(b)(c)</sup> | 228056 | &nbsp;&nbsp; 7719696 |
| Teradyne, Inc. | 61056 | &nbsp;&nbsp; 11105476 |
| Trimble, Inc.<sup>(b)</sup> | 91320 | &nbsp;&nbsp; 7435274 |
| VeriSign, Inc. | 35901 | &nbsp;&nbsp; 9046693 |
| Western Digital Corp. | 133277 | &nbsp;&nbsp; 21768132 |
| Wix.com Ltd. (Israel)<sup>(b)</sup> | 21461 | &nbsp;&nbsp; 2054032 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ Next Gen 100 ETF (QQQJ)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Information Technology-(continued)** | **Information Technology-(continued)** | **Information Technology-(continued)** |
| Zebra Technologies Corp., Class A<sup>(b)</sup> | 19519 | &nbsp;&nbsp; $4933427 |
| Zoom Communications, Inc., Class A<sup>(b)</sup> | 102274 | &nbsp;&nbsp; 8689199 |
|  |  | &nbsp;&nbsp; 246010118 |
| **Materials-1.30%** | **Materials-1.30%** | **Materials-1.30%** |
| Steel Dynamics, Inc. | 56515 | &nbsp;&nbsp; 9484913 |
| **Real Estate-0.92%** | **Real Estate-0.92%** | **Real Estate-0.92%** |
| Zillow Group, Inc., Class A<sup>(b)(c)</sup> | 19237 | &nbsp;&nbsp; 1391797 |
| Zillow Group, Inc., Class C<sup>(b)(c)</sup> | 71366 | &nbsp;&nbsp; 5308203 |
|  |  | &nbsp;&nbsp; 6700000 |
| **Utilities-2.83%** | **Utilities-2.83%** | **Utilities-2.83%** |
| Alliant Energy Corp. | 98627 | &nbsp;&nbsp; 6851618 |
| Evergy, Inc. | 88346 | &nbsp;&nbsp; 6860067 |
| Talen Energy Corp.<sup>(b)</sup> | 17539 | &nbsp;&nbsp; 6915101 |
|  |  | &nbsp;&nbsp; 20626786 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $579,539,298) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Common Stocks & Other Equity Interests <br>(Cost $579,539,298) | &nbsp;&nbsp; 727664995 |
| **Money Market Funds-0.01%** | **Money Market Funds-0.01%** | **Money Market Funds-0.01%** |
| &nbsp;&nbsp;&nbsp; Invesco Government & Agency Portfolio, <br> Institutional Class, 3.91%<sup>(d)(e)</sup> <br>(Cost $73,140)<br>| 73140 | &nbsp;&nbsp; 73140 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.95% <br>(Cost $579,612,438) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES <br>(excluding investments purchased with cash collateral <br> from securities on loan)-99.95% <br>(Cost $579,612,438) | &nbsp;&nbsp; 727738135 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** | **Investments Purchased with Cash Collateral from Securities** <br> **on Loan** |
| **Money Market Funds-9.36%** | **Money Market Funds-9.36%** | **Money Market Funds-9.36%** |
| &nbsp;&nbsp;&nbsp; Invesco Private Government Fund, <br> 4.00%<sup>(d)(e)(f)</sup><br>| 19171443 | &nbsp;&nbsp; $19171443 |
| Invesco Private Prime Fund, 4.12%<sup>(d)(e)(f)</sup> | 48991848 | &nbsp;&nbsp; 49006546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $68,177,989) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Investments Purchased with Cash Collateral from <br> Securities on Loan <br>(Cost $68,177,989) | &nbsp;&nbsp; 68177989 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.31% <br>(Cost $647,790,427) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-109.31% <br>(Cost $647,790,427) | &nbsp;&nbsp; 795916124 |
| OTHER ASSETS LESS LIABILITIES-(9.31)% | OTHER ASSETS LESS LIABILITIES-(9.31)% | &nbsp;&nbsp; (67769996)<br>|
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $728146128 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt <br> Rts. -Rights

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| <sup>(c)</sup> | All or a portion of this security was out on loan at November 30, 2025. |
| <sup>(d)</sup> | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the three months ended November 30, 2025.<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in** <br> **Affiliated Money** <br> **Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government <br> & Agency Portfolio, <br> Institutional Class<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $2843971 | &nbsp;&nbsp;&nbsp; $(2770831)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $73140 | &nbsp;&nbsp;&nbsp; $4070 |

---

See accompanying notes which are an integral part of this schedule.

------

**Invesco NASDAQ Next Gen 100 ETF (QQQJ)—(continued)**

November 30, 2025

*(Unaudited)*

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value**<br> **August 31, 2025**<br>| **Purchases**<br> **at Cost**<br>| **Proceeds**<br> **from Sales**<br>| **Change in**<br> **Unrealized**<br> **Appreciation**<br> **(Depreciation)**<br>| **Realized**<br> **Gain**<br>| **Value**<br> **November 30, 2025**<br>| **Dividend Income** |
| **Investments** <br> **Purchased with** <br> **Cash Collateral** <br> **from Securities on** <br> **Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private <br> Government Fund<br>| &nbsp;&nbsp;&nbsp; $24344293 | &nbsp;&nbsp;&nbsp; $75321683 | &nbsp;&nbsp;&nbsp; $(80494533)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $19171443 | &nbsp;&nbsp;&nbsp; $225,097<br> \*<br>|
| &nbsp;&nbsp; Invesco Private <br> Prime Fund<br>| &nbsp;&nbsp;&nbsp; 64666970 | &nbsp;&nbsp;&nbsp; 166541819 | &nbsp;&nbsp;&nbsp; (182200467)<br>| &nbsp;&nbsp;&nbsp; (4165)<br>| &nbsp;&nbsp;&nbsp; 2389 | &nbsp;&nbsp;&nbsp; 49006546 | &nbsp;&nbsp;&nbsp; 606,831<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $89011263 | &nbsp;&nbsp;&nbsp; $244707473 | &nbsp;&nbsp;&nbsp; $(265465831)<br>| &nbsp;&nbsp;&nbsp; $(4165)<br>| &nbsp;&nbsp;&nbsp; $2389 | &nbsp;&nbsp;&nbsp; $68251129 | &nbsp;&nbsp;&nbsp; $835998 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(e)</sup> The rate shown is the 7-day SEC standardized yield as of November 30, 2025. <br> <sup>(f)</sup> The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower's return of the securities loaned.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

Schedule of Investments<sup>(a)</sup>

**Invesco QQQ Low Volatility ETF (QQLV)**

November 30, 2025

*(Unaudited)*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Common Stocks & Other Equity Interests-99.82%** | **Common Stocks & Other Equity Interests-99.82%** | **Common Stocks & Other Equity Interests-99.82%** |
| **Consumer Discretionary-8.64%** | **Consumer Discretionary-8.64%** | **Consumer Discretionary-8.64%** |
| O'Reilly Automotive, Inc.<sup>(b)</sup> | 1701 | &nbsp;&nbsp; $172992 |
| Ross Stores, Inc. | 946 | &nbsp;&nbsp; 166836 |
|  |  | &nbsp;&nbsp; 339828 |
| **Consumer Staples-28.39%** | **Consumer Staples-28.39%** | **Consumer Staples-28.39%** |
| &nbsp;&nbsp;&nbsp; Coca-Cola Europacific Partners PLC (United <br> Kingdom)<br>| 1919 | &nbsp;&nbsp; 175953 |
| Costco Wholesale Corp. | 176 | &nbsp;&nbsp; 160792 |
| Keurig Dr Pepper, Inc. | 5110 | &nbsp;&nbsp; 142569 |
| Kraft Heinz Co. (The) | 5513 | &nbsp;&nbsp; 140637 |
| Mondelez International, Inc., Class A | 2660 | &nbsp;&nbsp; 153136 |
| Monster Beverage Corp.<sup>(b)</sup> | 2391 | &nbsp;&nbsp; 179301 |
| PepsiCo, Inc. | 1105 | &nbsp;&nbsp; 164358 |
|  |  | &nbsp;&nbsp; 1116746 |
| **Health Care-4.25%** | **Health Care-4.25%** | **Health Care-4.25%** |
| AstraZeneca PLC, ADR (United Kingdom) | 1804 | &nbsp;&nbsp; 167267 |
| **Industrials-23.06%** | **Industrials-23.06%** | **Industrials-23.06%** |
| Automatic Data Processing, Inc. | 614 | &nbsp;&nbsp; 156754 |
| Cintas Corp. | 673 | &nbsp;&nbsp; 125192 |
| Fastenal Co. | 2842 | &nbsp;&nbsp; 114817 |
| Honeywell International, Inc. | 691 | &nbsp;&nbsp; 132803 |
| Paychex, Inc. | 1059 | &nbsp;&nbsp; 118280 |

---

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value** |
| **Industrials-(continued)** | **Industrials-(continued)** | **Industrials-(continued)** |
| Thomson Reuters Corp. (Canada) | 867 | &nbsp;&nbsp; $117418 |
| Verisk Analytics, Inc. | 630 | &nbsp;&nbsp; 141794 |
|  |  | &nbsp;&nbsp; 907058 |
| **Information Technology-15.74%** | **Information Technology-15.74%** | **Information Technology-15.74%** |
| Cisco Systems, Inc. | 2294 | &nbsp;&nbsp; 176500 |
| Cognizant Technology Solutions Corp., Class A | 1970 | &nbsp;&nbsp; 153089 |
| Microsoft Corp. | 283 | &nbsp;&nbsp; 139239 |
| Roper Technologies, Inc. | 337 | &nbsp;&nbsp; 150376 |
|  |  | &nbsp;&nbsp; 619204 |
| **Materials-4.22%** | **Materials-4.22%** | **Materials-4.22%** |
| Linde PLC | 404 | &nbsp;&nbsp; 165769 |
| **Utilities-15.52%** | **Utilities-15.52%** | **Utilities-15.52%** |
| American Electric Power Co., Inc. | 1675 | &nbsp;&nbsp; 207315 |
| Exelon Corp. | 4235 | &nbsp;&nbsp; 199553 |
| Xcel Energy, Inc. | 2476 | &nbsp;&nbsp; 203304 |
|  |  | &nbsp;&nbsp; 610172 |
| &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-99.82% <br>(Cost $3,943,672) | &nbsp;&nbsp;&nbsp; TOTAL INVESTMENTS IN SECURITIES-99.82% <br>(Cost $3,943,672) | &nbsp;&nbsp; 3926044 |
| OTHER ASSETS LESS LIABILITIES-0.18% | OTHER ASSETS LESS LIABILITIES-0.18% | &nbsp;&nbsp; 6996 |
| NET ASSETS-100.00% | NET ASSETS-100.00% | &nbsp;&nbsp; $3933040 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Investment Abbreviations: <br> ADR -American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| Notes to Schedule of Investments: | Notes to Schedule of Investments: |
| <sup>(a)</sup> | Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is <br> the exclusive property and a service mark of MSCI Inc. and Standard & Poor's.<br>|
| <sup>(b)</sup> | Non-income producing security. |
| Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the period ended November 30, 2025. | Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in <br> which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund's transactions in, and earnings from, its investments in <br> affiliates for the period ended November 30, 2025. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Value** <br>**August 31, 2025**<br>| **Purchases** <br>**at Cost**<br>| **Proceeds** <br>**from Sales**<br>| **Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation)**<br>| **Realized** <br>**Gain**<br>| **Value** <br>**November 30, 2025**<br>| **Dividend Income** |
| **Investments in Affiliated** <br> **Money Market Funds:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Government & <br> Agency Portfolio, Institutional <br> Class<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $16552 | &nbsp;&nbsp;&nbsp; $(16552)<br>| &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $22 |
| **Investments Purchased with** <br> **Cash Collateral from** <br> **Securities on Loan:**<br>|  |  |  |  |  |  |  |
| &nbsp;&nbsp; Invesco Private Government <br> Fund<br>| &nbsp;&nbsp;&nbsp; 94026 | &nbsp;&nbsp;&nbsp; 93750 | &nbsp;&nbsp;&nbsp; (187776)<br>| &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 71<br> \*<br>|
| &nbsp;&nbsp; Invesco Private Prime Fund | &nbsp;&nbsp;&nbsp; 244597 | &nbsp;&nbsp;&nbsp; 239516 | &nbsp;&nbsp;&nbsp; (484113)<br>| &nbsp;&nbsp;&nbsp; (10)<br>| &nbsp;&nbsp;&nbsp; 10 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 204<br> \*<br>|
| &nbsp;&nbsp; Total | &nbsp;&nbsp;&nbsp; $338623 | &nbsp;&nbsp;&nbsp; $349818 | &nbsp;&nbsp;&nbsp; $(688441)<br>| &nbsp;&nbsp;&nbsp; $(10)<br>| &nbsp;&nbsp;&nbsp; $10 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $297 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.

The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.

See accompanying notes which are an integral part of this schedule.

------

**Notes to Quarterly Schedules of Portfolio Holdings**

November 30, 2025

*(Unaudited)*

**NOTE 1—Additional Valuation Information**

Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment's assigned level:

Level 1 — Prices are determined using quoted prices in an active market for identical assets.

Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others. When market movements occur after the close of the relevant foreign securities markets, foreign securities may be fair valued utilizing an independent pricing service.

Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect Invesco Capital Management LLC's assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.

The following is a summary of the tiered valuation input levels, as of November 30, 2025, for each Fund (except for Invesco QQQ Low Volatility ETF). As of November 30, 2025, all of the securities in Invesco QQQ Low Volatility ETF were valued based on Level 1 inputs (see the Schedules of Investments for security categories). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| &nbsp;&nbsp; Invesco ESG NASDAQ 100 ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $138144223 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $138144223 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 4943 | &nbsp;&nbsp;&nbsp; 338314 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 343257 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $138149166 | &nbsp;&nbsp;&nbsp; $338314 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $138487480 |
| &nbsp;&nbsp; Invesco ESG NASDAQ Next Gen 100 ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $6898359 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $6898359 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 4690 | &nbsp;&nbsp;&nbsp; 677717 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 682407 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $6903049 | &nbsp;&nbsp;&nbsp; $677717 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $7580766 |
| &nbsp;&nbsp; Invesco NASDAQ 100 ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $69877429913 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $69877429913 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 58755427 | &nbsp;&nbsp;&nbsp; 659586850 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 718342277 |
| **Total Investments in Securities** | &nbsp;&nbsp;&nbsp; 69936185340 | &nbsp;&nbsp;&nbsp; 659586850 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 70595772190 |
| **Other Investments - Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Futures Contracts | &nbsp;&nbsp;&nbsp; 3935157 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 3935157 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $69940120497 | &nbsp;&nbsp;&nbsp; $659586850 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $70599707347 |
| &nbsp;&nbsp; Invesco NASDAQ Future Gen 200 ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $12109985 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $3728 | &nbsp;&nbsp;&nbsp; $12113713 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 2692506 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 2692506 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $12109985 | &nbsp;&nbsp;&nbsp; $2692506 | &nbsp;&nbsp;&nbsp; $3728 | &nbsp;&nbsp;&nbsp; $14806219 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
| &nbsp;&nbsp; Invesco NASDAQ Next Gen 100 ETF |  |  |  |  |
| **Investments in Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Stocks & Other Equity Interests | &nbsp;&nbsp;&nbsp; $727664995 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $727664995 |
| &nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp;&nbsp; 73140 | &nbsp;&nbsp;&nbsp; 68177989 | &nbsp;&nbsp;&nbsp; - | &nbsp;&nbsp;&nbsp; 68251129 |
| **Total Investments** | &nbsp;&nbsp;&nbsp; $727738135 | &nbsp;&nbsp;&nbsp; $68177989 | &nbsp;&nbsp;&nbsp; $- | &nbsp;&nbsp;&nbsp; $795916124 |

---

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust II

- **b. Investment Company Act file number:** 811-21977

- **c. CIK number of Registrant:** 0001378872

- **d. LEI of Registrant:** O540V2L4S174Y60FMD36

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco NASDAQ Future Gen 200 ETF

- **b. EDGAR series identifier (if any):** S000077288

- **c. LEI of Series:** 549300GPI35ZCTF27915

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-08-31

- **b. Date as of which information is reported:** 2025-11-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $14864439.62

**Total Liabilities:** $2694426.89

**Net Assets:** $12170012.73

**Cash Not Reported:** $6451.35

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000237581 | 10.80%               | 5.30%                | -1.19%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $558059.79               | $394973.94                                 |
| Month 2  | $14736.46                | $529831.61                                 |
| Month 3  | $-28619.85               | $-133935.17                                |

### Schedule of Portfolio Investments

| Name                                    | Title                                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| LivaNova PLC                            | LivaNova PLC                                   | CUSIP: G5509L101<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |       956 | NS      | $61002.36     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Kura Oncology, Inc.                     | Kura Oncology, Inc.                            | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |      6854 | NS      | $83207.56     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Voyager Therapeutics, Inc.              | Voyager Therapeutics, Inc.                     | CUSIP: 92915B106<br>LEI: 54930082S4XVR0ZWCC74 | Long             | EC               | CORP              | US        |     16032 | NS      | $65570.88     | 0.54%             |  |  |  | No            |                  1 | On Loan: —       |
| Ionis Pharmaceuticals, Inc.             | Ionis Pharmaceuticals, Inc.                    | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      1270 | NS      | $105067.10    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva, Inc.                          | Innoviva, Inc.                                 | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |      2653 | NS      | $57649.69     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Editas Medicine, Inc.                   | Editas Medicine, Inc.                          | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               | CORP              | US        |     20966 | NS      | $50528.06     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| DENTSPLY SIRONA Inc.                    | DENTSPLY SIRONA Inc.                           | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |      3767 | NS      | $42717.78     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Corvus Pharmaceuticals, Inc.            | Corvus Pharmaceuticals, Inc.                   | CUSIP: 221015100<br>LEI: 549300I3AVJ8F75NCX65 | Long             | EC               | CORP              | US        |      9446 | NS      | $86619.82     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals, Inc.         | Arrowhead Pharmaceuticals, Inc.                | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |      2455 | NS      | $129378.50    | 1.06%             |  |  |  | No            |                  1 | On Loan: —       |
| Energy Recovery, Inc.                   | Energy Recovery, Inc.                          | CUSIP: 29270J100<br>LEI: 549300ZEQL52Z525WJ22 | Long             | EC               | CORP              | US        |      3791 | NS      | $54779.95     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Aviat Networks, Inc.                    | Aviat Networks, Inc.                           | CUSIP: 05366Y201<br>LEI: 549300Z3X8Z4MK52CI65 | Long             | EC               | CORP              | US        |      2363 | NS      | $52245.93     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Axcelis Technologies, Inc.              | Axcelis Technologies, Inc.                     | CUSIP: 054540208<br>LEI: 529900HF9B6NL1QG9F05 | Long             | EC               | CORP              | US        |       678 | NS      | $56118.06     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Vuzix Corp.                             | Vuzix Corp.                                    | CUSIP: 92921W300<br>LEI: 549300EWPW64TZQXJG66 | Long             | EC               | CORP              | US        |     25562 | NS      | $68761.78     | 0.57%             |  |  |  | No            |                  1 | On Loan: —       |
| Alphatec Holdings, Inc.                 | Alphatec Holdings, Inc.                        | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |      3405 | NS      | $76782.75     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Tactile Systems Technology, Inc.        | Tactile Systems Technology, Inc.               | CUSIP: 87357P100<br>LEI: 54930069VDTITHOTKJ98 | Long             | EC               | CORP              | US        |      4069 | NS      | $104613.99    | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| DMC Global Inc.                         | DMC Global Inc.                                | CUSIP: 23291C103<br>LEI: 549300CBDXD1Z5MRNG02 | Long             | EC               | CORP              | US        |      8045 | NS      | $49959.45     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| KalVista Pharmaceuticals, Inc.          | KalVista Pharmaceuticals, Inc.                 | CUSIP: 483497103<br>LEI: 529900Q7IDA3WUGRZA51 | Long             | EC               | CORP              | US        |      4002 | NS      | $57908.94     | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Power Integrations, Inc.                | Power Integrations, Inc.                       | CUSIP: 739276103<br>LEI: 54930085LGXSCIHD5W31 | Long             | EC               | CORP              | US        |      1194 | NS      | $40118.40     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Conduent Inc.                           | Conduent Inc.                                  | CUSIP: 206787103<br>LEI: 549300SFJ2D2CYY6CQ11 | Long             | EC               | CORP              | US        |     19489 | NS      | $37808.66     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Varex Imaging Corp.                     | Varex Imaging Corp.                            | CUSIP: 92214X106<br>LEI: 549300CWYWPVCT8E9W67 | Long             | EC               | CORP              | US        |      4694 | NS      | $54309.58     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| MannKind Corp.                          | MannKind Corp.                                 | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |     11736 | NS      | $62787.60     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Digimarc Corp.                          | Digimarc Corp.                                 | CUSIP: 25381B101<br>LEI: 254900TL728B5T0M5R41 | Long             | EC               | CORP              | US        |      6267 | NS      | $50198.67     | 0.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Atomera Inc.                            | Atomera Inc.                                   | CUSIP: 04965B100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16416 | NS      | $40711.68     | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| CryoPort, Inc.                          | CryoPort, Inc.                                 | CUSIP: 229050307<br>LEI: 9845004D8538BT8JF626 | Long             | EC               | CORP              | US        |      6081 | NS      | $58499.22     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics, Inc.           | Iovance Biotherapeutics, Inc.                  | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |     24146 | NS      | $59640.62     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Roku, Inc.                              | Roku, Inc., Class A                            | CUSIP: 77543R102<br>LEI: 549300KR6ITU0YIR1T71 | Long             | EC               | CORP              | US        |       562 | NS      | $54395.98     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Tandem Diabetes Care, Inc.              | Tandem Diabetes Care, Inc.                     | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |      4331 | NS      | $90994.31     | 0.75%             |  |  |  | No            |                  1 | On Loan: —       |
| OrthoPediatrics Corp.                   | OrthoPediatrics Corp.                          | CUSIP: 68752L100<br>LEI: 5493000KUTPFGOPAT717 | Long             | EC               | CORP              | US        |      2521 | NS      | $46613.29     | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| Sleep Number Corp.                      | Sleep Number Corp.                             | CUSIP: 83125X103<br>LEI: 529900W0TZQLBT2DSS66 | Long             | EC               | CORP              | US        |      5119 | NS      | $26106.90     | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Spero Therapeutics, Inc.                | Spero Therapeutics, Inc.                       | CUSIP: 84833T103<br>LEI: 54930074G13LHWJT2323 | Long             | EC               | CORP              | US        |     26176 | NS      | $62822.40     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Bandwidth Inc.                          | Bandwidth Inc., Class A                        | CUSIP: 05988J103<br>LEI: 549300QC70JB7MUGXM66 | Long             | EC               | CORP              | US        |      3591 | NS      | $51135.84     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Stitch Fix, Inc.                        | Stitch Fix, Inc., Class A                      | CUSIP: 860897107<br>LEI: 549300TNHOVBOJZIYE72 | Long             | EC               | CORP              | US        |     10264 | NS      | $43622.00     | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Ribbon Communications Inc.              | Ribbon Communications Inc.                     | CUSIP: 762544104<br>LEI: 549300L1E8Z8RL7CUL52 | Long             | EC               | CORP              | US        |     13197 | NS      | $37743.42     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Quanterix Corp.                         | Quanterix Corp.                                | CUSIP: 74766Q101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11909 | NS      | $86459.34     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| TTEC Holdings, Inc.                     | TTEC Holdings, Inc.                            | CUSIP: 89854H102<br>LEI: GTJS1N8S8I28A7L4WG97 | Long             | EC               | CORP              | US        |     14322 | NS      | $48121.92     | 0.40%             |  |  |  | No            |                  1 | On Loan: —       |
| Dropbox, Inc.                           | Dropbox, Inc., Class A                         | CUSIP: 26210C104<br>LEI: 549300JCDF7UAR6TJR51 | Long             | EC               | CORP              | US        |      1866 | NS      | $55756.08     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Gentex Corp.                            | Gentex Corp.                                   | CUSIP: 371901109<br>LEI: 549300S3UD8XV1MN0287 | Long             | EC               | CORP              | US        |      1939 | NS      | $44267.37     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| iQIYI, Inc.                             | iQIYI, Inc., ADR                               | CUSIP: 46267X108<br>LEI: 222100XL8T2Q5B8MS302 | Long             | EC               | CORP              | KY        |     20321 | NS      | $44502.99     | 0.37%             |  |  |  | No            |                  1 | On Loan: —       |
| Turtle Beach Corp.                      | Turtle Beach Corp.                             | CUSIP: 900450206<br>LEI: 549300SZRV8U8PXSYI20 | Long             | EC               | CORP              | US        |      3430 | NS      | $47608.40     | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| nLight, Inc.                            | nLight, Inc.                                   | CUSIP: 65487K100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1881 | NS      | $66267.63     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Gevo, Inc.                              | Gevo, Inc.                                     | CUSIP: 374396406<br>LEI: 549300IV6EW4O1OJD686 | Long             | EC               | CORP              | US        |     31143 | NS      | $66646.02     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Autolus Therapeutics PLC                | Autolus Therapeutics PLC, ADR                  | CUSIP: 05280R100<br>LEI: 549300C0KZP8EYROLL02 | Long             | EC               | CORP              | GB        |     35898 | NS      | $50616.18     | 0.42%             |  |  |  | No            |                  1 | On Loan: —       |
| Lovesac Co. (The)                       | Lovesac Co. (The)                              | CUSIP: 54738L109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2813 | NS      | $40366.55     | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| Neuronetics, Inc.                       | Neuronetics, Inc.                              | CUSIP: 64131A105<br>LEI: 549300T0911ILTTG7P06 | Long             | EC               | CORP              | US        |     16170 | NS      | $24093.30     | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Aquestive Therapeutics, Inc.            | Aquestive Therapeutics, Inc.                   | CUSIP: 03843E104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14372 | NS      | $88962.68     | 0.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Orthofix Medical Inc.                   | Orthofix Medical Inc.                          | CUSIP: 68752M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3596 | NS      | $57859.64     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonos, Inc.                             | Sonos, Inc.                                    | CUSIP: 83570H108<br>LEI: 549300WEPU6075I77M08 | Long             | EC               | CORP              | US        |      3874 | NS      | $71901.44     | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| AudioEye, Inc.                          | AudioEye, Inc.                                 | CUSIP: 050734201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4197 | NS      | $51874.92     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune, Inc.                         | Altimmune, Inc.                                | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |     14138 | NS      | $74365.88     | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| BRP Inc.                                | BRP Inc.                                       | CUSIP: 05577W200<br>LEI: 529900EPQGESIRCPY551 | Long             | EC               | CORP              | CA        |       861 | NS      | $59503.71     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Garrett Motion Inc.                     | Garrett Motion Inc.                            | CUSIP: 366505105<br>LEI: 549300LS5WT7EMBNV724 | Long             | EC               | CORP              | US        |      4170 | NS      | $68930.10     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas, Inc.                           | Arvinas, Inc.                                  | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7013 | NS      | $88258.61     | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics, Inc.             | Allogene Therapeutics, Inc.                    | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47702 | NS      | $69644.92     | 0.57%             |  |  |  | No            |                  1 | On Loan: —       |
| SI-BONE, Inc.                           | SI-BONE, Inc.                                  | CUSIP: 825704109<br>LEI: 549300J8JGYVJJHV9C31 | Long             | EC               | CORP              | US        |      3249 | NS      | $63225.54     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| MasterCraft Boat Holdings, Inc.         | MasterCraft Boat Holdings, Inc.                | CUSIP: 57637H103<br>LEI: 549300IXWX41555YJ117 | Long             | EC               | CORP              | US        |      2454 | NS      | $45349.92     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Alector, Inc.                           | Alector, Inc.                                  | CUSIP: 014442107<br>LEI: 549300Z8RQOIY1JMHC25 | Long             | EC               | CORP              | US        |     22927 | NS      | $30492.91     | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Lyft, Inc.                              | Lyft, Inc., Class A                            | CUSIP: 55087P104<br>LEI: 549300H7I5VN334XVZ52 | Long             | EC               | CORP              | US        |      3340 | NS      | $70240.20     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Advanced Energy Industries, Inc.        | Advanced Energy Industries, Inc.               | CUSIP: 007973100<br>LEI: 549300756XI3QLFT2U27 | Long             | EC               | CORP              | US        |       362 | NS      | $76450.78     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeco Instruments Inc.                  | Veeco Instruments Inc.                         | CUSIP: 922417100<br>LEI: 5493004201F72ADDZW04 | Long             | EC               | CORP              | US        |      2198 | NS      | $64247.54     | 0.53%             |  |  |  | No            |                  1 | On Loan: —       |
| BioCryst Pharmaceuticals, Inc.          | BioCryst Pharmaceuticals, Inc.                 | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |      6479 | NS      | $46519.22     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp.                             | Geron Corp.                                    | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |     38461 | NS      | $45383.98     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Rambus Inc.                             | Rambus Inc.                                    | CUSIP: 750917106<br>LEI: 2549000211GDCQSLV833 | Long             | EC               | CORP              | US        |       731 | NS      | $69861.67     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Kopin Corp.                             | Kopin Corp.                                    | CUSIP: 500600101<br>LEI: 52990031GUBB61RXCD89 | Long             | EC               | CORP              | US        |     25658 | NS      | $62605.52     | 0.51%             |  |  |  | No            |                  1 | On Loan: —       |
| Extreme Networks, Inc.                  | Extreme Networks, Inc.                         | CUSIP: 30226D106<br>LEI: 549300WRECW11X94UB57 | Long             | EC               | CORP              | US        |      2519 | NS      | $44082.50     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems, Inc.             | Merit Medical Systems, Inc.                    | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |       599 | NS      | $51867.41     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Helen of Troy Ltd.                      | Helen of Troy Ltd.                             | CUSIP: G4388N106<br>LEI: N/A                  | Long             | EC               | CORP              | BM        |      2195 | NS      | $41595.25     | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| iHeartMedia, Inc.                       | iHeartMedia, Inc., Class A                     | CUSIP: 45174J509<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25440 | NS      | $99979.20     | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Cohu, Inc.                              | Cohu, Inc.                                     | CUSIP: 192576106<br>LEI: 529900FJPORJ3JJ2XS33 | Long             | EC               | CORP              | US        |      2707 | NS      | $65834.24     | 0.54%             |  |  |  | No            |                  1 | On Loan: —       |
| MillerKnoll, Inc.                       | MillerKnoll, Inc.                              | CUSIP: 600544100<br>LEI: U98HXD3PNK7HYU2MU887 | Long             | EC               | CORP              | US        |      2553 | NS      | $40413.99     | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Display Corp.                 | Universal Display Corp.                        | CUSIP: 91347P105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       388 | NS      | $46144.84     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Bel Fuse Inc.                           | Bel Fuse Inc., Class B                         | CUSIP: 077347300<br>LEI: 2549009L4XYDBRRY6X39 | Long             | EC               | CORP              | US        |       403 | NS      | $62074.09     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| AngioDynamics, Inc.                     | AngioDynamics, Inc.                            | CUSIP: 03475V101<br>LEI: 549300W3VKC5ZKMO8C28 | Long             | EC               | CORP              | US        |      5281 | NS      | $65484.40     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Bicycle Therapeutics PLC                | Bicycle Therapeutics PLC, ADR                  | CUSIP: 088786108<br>LEI: 213800XKUI6R7GKC3E43 | Long             | EC               | CORP              | GB        |      7294 | NS      | $54559.12     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Personalis, Inc.                        | Personalis, Inc.                               | CUSIP: 71535D106<br>LEI: 549300EZ2NYFK7H0US48 | Long             | EC               | CORP              | US        |     11071 | NS      | $118791.83    | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp.          | Adaptive Biotechnologies Corp.                 | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |      4114 | NS      | $80881.24     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Xerox Holdings Corp.                    | Xerox Holdings Corp.                           | CUSIP: 98421M106<br>LEI: 5493000Y33XDVO2CXC18 | Long             | EC               | CORP              | US        |     13614 | NS      | $37846.92     | 0.31%             |  |  |  | No            |                  1 | On Loan: —       |
| IPG Photonics Corp.                     | IPG Photonics Corp.                            | CUSIP: 44980X109<br>LEI: 5493002KZ51CADQ94G15 | Long             | EC               | CORP              | US        |       662 | NS      | $52721.68     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| 10x Genomics, Inc.                      | 10x Genomics, Inc., Class A                    | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |      3872 | NS      | $72832.32     | 0.60%             |  |  |  | No            |                  1 | On Loan: —       |
| Exagen Inc.                             | Exagen Inc.                                    | CUSIP: 30068X103<br>LEI: 549300JV2CYDOME5OO17 | Long             | EC               | CORP              | US        |      5461 | NS      | $43141.90     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocugen, Inc.                            | Ocugen, Inc.                                   | CUSIP: 67577C105<br>LEI: 549300JVNUI9CXWJLR09 | Long             | EC               | CORP              | US        |     52807 | NS      | $65480.68     | 0.54%             |  |  |  | No            |                  1 | On Loan: —       |
| Vir Biotechnology, Inc.                 | Vir Biotechnology, Inc.                        | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10914 | NS      | $70067.88     | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| JOYY Inc.                               | JOYY Inc., ADR                                 | CUSIP: 46591M109<br>LEI: 549300N6CHVU5CQZPW24 | Long             | EC               | CORP              | KY        |      1003 | NS      | $63309.36     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| ClearPoint Neuro, Inc.                  | ClearPoint Neuro, Inc.                         | CUSIP: 18507C103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5161 | NS      | $74628.06     | 0.61%             |  |  |  | No            |                  1 | On Loan: —       |
| Cirrus Logic, Inc.                      | Cirrus Logic, Inc.                             | CUSIP: 172755100<br>LEI: 549300NKSJEM5ZZSSV18 | Long             | EC               | CORP              | US        |       472 | NS      | $56800.48     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Government Fund         | Invesco Private Government Fund                | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |    737178 | NS      | $737177.66    | 6.06%             |  |  |  | No            |                  2 | On Loan: No      |
| Agora, Inc.                             | Agora, Inc., ADR                               | CUSIP: 00851L103<br>LEI: 5493001S8SBPD13GC964 | Long             | EC               | CORP              | KY        |     15702 | NS      | $56684.22     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Prime Fund              | Invesco Private Prime Fund                     | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |   1955328 | NS      | $1955328.42   | 16.07%            |  |  |  | No            |                  2 | On Loan: No      |
| Allegro Microsystems, Inc.              | Allegro Microsystems, Inc.                     | CUSIP: 01749D105<br>LEI: 54930004TGPV6DR3LE12 | Long             | EC               | CORP              | US        |      1760 | NS      | $46974.40     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Central Garden & Pet Co.                | Central Garden & Pet Co.                       | CUSIP: 153527106<br>LEI: 5493004DVZLD37DJ0H83 | Long             | EC               | CORP              | US        |      1477 | NS      | $50454.32     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Itron, Inc.                             | Itron, Inc.                                    | CUSIP: 465741106<br>LEI: 24F6LSZD18II6ICG6S41 | Long             | EC               | CORP              | US        |       438 | NS      | $43379.52     | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Silicon Laboratories Inc.               | Silicon Laboratories Inc.                      | CUSIP: 826919102<br>LEI: 4PRDF8Q9TDHRVZKZSZ47 | Long             | EC               | CORP              | US        |       404 | NS      | $51542.32     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviz Technologies Ltd.               | Innoviz Technologies Ltd.                      | CUSIP: M5R635108<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |     32267 | NS      | $41301.76     | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| Omeros Corp.                            | Omeros Corp.                                   | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |     13007 | NS      | $126037.83    | 1.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Viasat, Inc.                            | Viasat, Inc.                                   | CUSIP: 92552V100<br>LEI: UFC8NYMNFSYIHNSM2I38 | Long             | EC               | CORP              | US        |      1668 | NS      | $57262.44     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Atai Beckley N.V.                       | Atai Beckley N.V.                              | CUSIP: N0731H103<br>LEI: 391200Z8UWPJSNBNCA11 | Long             | EC               | CORP              | NL        |     11771 | NS      | $45789.19     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics, Inc.                   | Myriad Genetics, Inc.                          | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |      8501 | NS      | $64862.63     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| MaxCyte, Inc.                           | MaxCyte, Inc.                                  | CUSIP: 57777K106<br>LEI: 54930053YHXULRFCU991 | Long             | EC               | CORP              | US        |     38775 | NS      | $68244.00     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbe Robotics Ltd.                      | Arbe Robotics Ltd.                             | CUSIP: M1R95N100<br>LEI: N/A                  | Long             | EC               | CORP              | IL        |     41417 | NS      | $60882.99     | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| Navitas Semiconductor Corp.             | Navitas Semiconductor Corp.                    | CUSIP: 63942X106<br>LEI: 529900T4K9WALWC76S49 | Long             | EC               | CORP              | US        |      9200 | NS      | $80408.00     | 0.66%             |  |  |  | No            |                  1 | On Loan: —       |
| Ventyx Biosciences, Inc.                | Ventyx Biosciences, Inc.                       | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22536 | NS      | $225360.00    | 1.85%             |  |  |  | No            |                  1 | On Loan: —       |
| ICU Medical, Inc.                       | ICU Medical, Inc.                              | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |       422 | NS      | $62641.68     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| OraSure Technologies, Inc.              | OraSure Technologies, Inc.                     | CUSIP: 68554V108<br>LEI: 529900GNNJPNM4XHXQ77 | Long             | EC               | CORP              | US        |     16424 | NS      | $39089.12     | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Codexis, Inc.                           | Codexis, Inc.                                  | CUSIP: 192005106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19726 | NS      | $34125.98     | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Alpha and Omega Semiconductor Ltd.      | Alpha and Omega Semiconductor Ltd.             | CUSIP: G6331P104<br>LEI: 5493001FE7J03YOV2V35 | Long             | EC               | CORP              | BM        |      1888 | NS      | $38288.64     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp.     | Integra LifeSciences Holdings Corp.            | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |      3560 | NS      | $46707.20     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp.                           | Embecta Corp.                                  | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |      3747 | NS      | $47792.99     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| AtriCure, Inc.                          | AtriCure, Inc.                                 | CUSIP: 04963C209<br>LEI: 254900B2I6GPHK2EXM59 | Long             | EC               | CORP              | US        |      1458 | NS      | $52662.96     | 0.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Amicus Therapeutics, Inc.               | Amicus Therapeutics, Inc.                      | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |      7136 | NS      | $70860.48     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Canadian Solar Inc.                     | Canadian Solar Inc.                            | CUSIP: 136635109<br>LEI: 5493001XSC6TKMBVOM15 | Long             | EC               | CORP              | CA        |      5534 | NS      | $150248.10    | 1.23%             |  |  |  | No            |                  1 | On Loan: —       |
| Heron Therapeutics, Inc.                | Heron Therapeutics, Inc.                       | CUSIP: 427746102<br>LEI: 549300DR2I1DOPD2IX53 | Long             | EC               | CORP              | US        |     39887 | NS      | $46268.92     | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| Pro-Dex, Inc.                           | Pro-Dex, Inc.                                  | CUSIP: 74265M205<br>LEI: 529900EB2AJA079NT411 | Long             | EC               | CORP              | US        |      1150 | NS      | $41906.00     | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| MaxLinear, Inc.                         | MaxLinear, Inc.                                | CUSIP: 57776J100<br>LEI: 549300EMOI0SM2IY4F64 | Long             | EC               | CORP              | US        |      3427 | NS      | $53358.39     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Anika Therapeutics, Inc.                | Anika Therapeutics, Inc.                       | CUSIP: 035255108<br>LEI: 529900R9LS3Z0O6QH455 | Long             | EC               | CORP              | US        |      5740 | NS      | $56711.20     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc.        | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |     41354 | NS      | $95941.28     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| OmniAb, Inc.                            | OmniAb, Inc., Rts., 2027-11-02                 | CUSIP: 68218J202<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |        83 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| OmniAb, Inc.                            | OmniAb, Inc., Rts., expiring 2027-11-02        | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |        83 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Standard BioTools Inc.                  | Standard BioTools Inc.                         | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |     42752 | NS      | $64128.00     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Semtech Corp.                           | Semtech Corp.                                  | CUSIP: 816850101<br>LEI: 549300J7WUY317SW6O61 | Long             | EC               | CORP              | US        |       932 | NS      | $69117.12     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira Biosciences, Inc.                | Pacira Biosciences, Inc.                       | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2020 | NS      | $47611.40     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Amkor Technology, Inc.                  | Amkor Technology, Inc.                         | CUSIP: 031652100<br>LEI: 529900VHLRTKPWZJBM84 | Long             | EC               | CORP              | US        |      2239 | NS      | $81477.21     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Cartesian Therapeutics, Inc.            | Cartesian Therapeutics, Inc., Rts., 2050-12-31 | CUSIP: 816212112<br>LEI: 529900NMN0LACZOL7C43 | Long             | EC               | CORP              | US        |     27325 | NS      | $3727.95      | 0.03%             |  |  |  | No            |                  3 | On Loan: No      |
| Mitek Systems, Inc.                     | Mitek Systems, Inc.                            | CUSIP: 606710200<br>LEI: 549300ABZAQ3R25XG118 | Long             | EC               | CORP              | US        |      5334 | NS      | $47259.24     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta, Inc.                            | Azenta, Inc.                                   | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |      1764 | NS      | $62727.84     | 0.52%             |  |  |  | No            |                  1 | On Loan: —       |
| OPKO Health, Inc.                       | OPKO Health, Inc.                              | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |     39277 | NS      | $53416.72     | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| EchoStar Corp.                          | EchoStar Corp., Class A                        | CUSIP: 278768106<br>LEI: 549300EE20907QZ9GT38 | Long             | EC               | CORP              | US        |       873 | NS      | $63982.17     | 0.53%             |  |  |  | No            |                  1 | On Loan: —       |
| Netgear, Inc.                           | Netgear, Inc.                                  | CUSIP: 64111Q104<br>LEI: 54930067KX3UNRHDWA78 | Long             | EC               | CORP              | US        |      1985 | NS      | $52503.25     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| MicroVision, Inc.                       | MicroVision, Inc.                              | CUSIP: 594960304<br>LEI: 5299001A8NIHHA9KOY43 | Long             | EC               | CORP              | US        |     46867 | NS      | $44144.03     | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Supernus Pharmaceuticals, Inc.          | Supernus Pharmaceuticals, Inc.                 | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |      1193 | NS      | $54388.87     | 0.45%             |  |  |  | No            |                  1 | On Loan: —       |
| Silicon Motion Technology Corp.         | Silicon Motion Technology Corp., ADR           | CUSIP: 82706C108<br>LEI: 5299005RBVBZQJTYFC89 | Long             | EC               | CORP              | KY        |       681 | NS      | $60581.76     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Gentherm Inc.                           | Gentherm Inc.                                  | CUSIP: 37253A103<br>LEI: HKM6YX1U5JS60TCUB219 | Long             | EC               | CORP              | US        |      1465 | NS      | $52256.55     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Scilex Holding Co.                      | Scilex Holding Co., Class C                    | CUSIP: 80880W205<br>LEI: N/A                  | Long             | EC               | CORP              | US        |        72 | NS      | $1465.92      | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                     | Nektar Therapeutics                            | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      1815 | NS      | $118356.15    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Stratasys Ltd.                          | Stratasys Ltd.                                 | CUSIP: M85548101<br>LEI: 529900MU215GIP9SZ741 | Long             | EC               | CORP              | IL        |      5098 | NS      | $44811.42     | 0.37%             |  |  |  | No            |                  1 | On Loan: —       |
| Prothena Corp. PLC                      | Prothena Corp. PLC                             | CUSIP: G72800108<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |      6605 | NS      | $71003.75     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Enanta Pharmaceuticals, Inc.            | Enanta Pharmaceuticals, Inc.                   | CUSIP: 29251M106<br>LEI: 529900SSN4DODDQSN594 | Long             | EC               | CORP              | US        |      6450 | NS      | $91074.00     | 0.75%             |  |  |  | No            |                  1 | On Loan: —       |
| Allot Ltd.                              | Allot Ltd.                                     | CUSIP: M0854Q105<br>LEI: 5493008MLSB5KCVNRK06 | Long             | EC               | CORP              | IL        |      6856 | NS      | $65680.48     | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Newell Brands Inc.                      | Newell Brands Inc.                             | CUSIP: 651229106<br>LEI: 549300LWGYFM1TVO1Z12 | Long             | EC               | CORP              | US        |      9096 | NS      | $33200.40     | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| MiMedx Group, Inc.                      | MiMedx Group, Inc.                             | CUSIP: 602496101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7639 | NS      | $52556.32     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Goodyear Tire & Rubber Co. (The)        | Goodyear Tire & Rubber Co. (The)               | CUSIP: 382550101<br>LEI: 5493002BI0S2ZQUY3437 | Long             | EC               | CORP              | US        |      6395 | NS      | $55380.70     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                  | PTC Therapeutics, Inc.                         | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |      1099 | NS      | $94503.01     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Gogo Inc.                               | Gogo Inc.                                      | CUSIP: 38046C109<br>LEI: 549300VL3DIHSFHYTO04 | Long             | EC               | CORP              | US        |      4908 | NS      | $35092.20     | 0.29%             |  |  |  | No            |                  1 | On Loan: —       |
| Esperion Therapeutics, Inc.             | Esperion Therapeutics, Inc.                    | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |     24414 | NS      | $97900.14     | 0.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Arq, Inc.                               | Arq, Inc.                                      | CUSIP: 00770C101<br>LEI: 52990086HRJSW2EZQH40 | Long             | EC               | CORP              | US        |      6973 | NS      | $25939.56     | 0.21%             |  |  |  | No            |                  1 | On Loan: —       |
| Agios Pharmaceuticals, Inc.             | Agios Pharmaceuticals, Inc.                    | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |      1429 | NS      | $41726.80     | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Vanda Pharmaceuticals Inc.              | Vanda Pharmaceuticals Inc.                     | CUSIP: 921659108<br>LEI: 529900AY8VOOQBKJ0O70 | Long             | EC               | CORP              | US        |     11456 | NS      | $61404.16     | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| Fox Factory Holding Corp.               | Fox Factory Holding Corp.                      | CUSIP: 35138V102<br>LEI: 529900GE1HSV0617R721 | Long             | EC               | CORP              | US        |      1861 | NS      | $27524.19     | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen, Inc.                            | Axogen, Inc.                                   | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3357 | NS      | $96178.05     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Optoelectronics, Inc.           | Applied Optoelectronics, Inc.                  | CUSIP: 03823U102<br>LEI: 529900I8U6Q5SYDNLT48 | Long             | EC               | CORP              | US        |      2229 | NS      | $59692.62     | 0.49%             |  |  |  | No            |                  1 | On Loan: —       |
| Fate Therapeutics, Inc.                 | Fate Therapeutics, Inc.                        | CUSIP: 31189P102<br>LEI: 549300L14Q4UHOODLA90 | Long             | EC               | CORP              | US        |     51772 | NS      | $59020.08     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| CommScope Holding Co., Inc.             | CommScope Holding Co., Inc.                    | CUSIP: 20337X109<br>LEI: 254900AW4CEPCQWSRI58 | Long             | EC               | CORP              | US        |      3375 | NS      | $66622.50     | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Kulicke and Soffa Industries, Inc.      | Kulicke and Soffa Industries, Inc.             | CUSIP: 501242101<br>LEI: 529900H6BEIRBF429744 | Long             | EC               | CORP              | US        |      1437 | NS      | $64823.07     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Diodes Inc.                             | Diodes Inc.                                    | CUSIP: 254543101<br>LEI: 549300XP2X1ARVH3BX23 | Long             | EC               | CORP              | US        |       990 | NS      | $45747.90     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Ballard Power Systems Inc.              | Ballard Power Systems Inc.                     | CUSIP: 058586108<br>LEI: 549300OHZ8BMF53YYS26 | Long             | EC               | CORP              | CA        |     26850 | NS      | $76254.00     | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicell, Inc.                          | Omnicell, Inc.                                 | CUSIP: 68213N109<br>LEI: 5493008RH0GTKHHPZI77 | Long             | EC               | CORP              | US        |      1665 | NS      | $60789.15     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Innovative Solutions and Support, Inc.  | Innovative Solutions and Support, Inc.         | CUSIP: 45769N105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4159 | NS      | $40508.66     | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| Matthews International Corp.            | Matthews International Corp., Class A          | CUSIP: 577128101<br>LEI: 549300ZVC5O0ATML6U61 | Long             | EC               | CORP              | US        |      2192 | NS      | $53791.68     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor, Inc.                            | Xencor, Inc.                                   | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |      6655 | NS      | $115264.60    | 0.95%             |  |  |  | No            |                  1 | On Loan: —       |
| uniQure N.V.                            | uniQure N.V.                                   | CUSIP: N90064101<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |      3317 | NS      | $91250.67     | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Inogen, Inc.                            | Inogen, Inc.                                   | CUSIP: 45780L104<br>LEI: 549300J8WJIVTOJ8IH97 | Long             | EC               | CORP              | US        |      6793 | NS      | $48094.44     | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Akebia Therapeutics, Inc.               | Akebia Therapeutics, Inc.                      | CUSIP: 00972D105<br>LEI: 549300CBQEHMKEEGNX42 | Long             | EC               | CORP              | US        |     17148 | NS      | $27093.84     | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| MediWound Ltd.                          | MediWound Ltd.                                 | CUSIP: M68830112<br>LEI: 549300LJKCS74GRYKF90 | Long             | EC               | CORP              | IL        |      3226 | NS      | $57809.92     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp.              | Phibro Animal Health Corp., Class A            | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      1463 | NS      | $61270.44     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| AeroVironment, Inc.                     | AeroVironment, Inc.                            | CUSIP: 008073108<br>LEI: 529900PGHVI29YLZ6221 | Long             | EC               | CORP              | US        |       225 | NS      | $62878.50     | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Aldeyra Therapeutics, Inc.              | Aldeyra Therapeutics, Inc.                     | CUSIP: 01438T106<br>LEI: 529900HGKY864E4Y9014 | Long             | EC               | CORP              | US        |      9218 | NS      | $50514.64     | 0.42%             |  |  |  | No            |                  1 | On Loan: —       |
| Innospec Inc.                           | Innospec Inc.                                  | CUSIP: 45768S105<br>LEI: 213800SQBACNY5IWJO68 | Long             | EC               | CORP              | US        |       617 | NS      | $46126.92     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc.               | Theravance Biopharma Inc.                      | CUSIP: G8807B106<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |      3906 | NS      | $79291.80     | 0.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Lattice Semiconductor Corp.             | Lattice Semiconductor Corp.                    | CUSIP: 518415104<br>LEI: 549300LRBBPZDQ2II567 | Long             | EC               | CORP              | US        |       816 | NS      | $57291.36     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Littelfuse, Inc.                        | Littelfuse, Inc.                               | CUSIP: 537008104<br>LEI: 549300MY7HLQFYTPCX75 | Long             | EC               | CORP              | US        |       208 | NS      | $53252.16     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| MKS Inc.                                | MKS Inc.                                       | CUSIP: 55306N104<br>LEI: 549300KEQATBHAGVF505 | Long             | EC               | CORP              | US        |       522 | NS      | $81635.58     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc.             | Ligand Pharmaceuticals Inc.                    | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |       335 | NS      | $68065.30     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Synaptics Inc.                          | Synaptics Inc.                                 | CUSIP: 87157D109<br>LEI: 549300AJ3LI4FWNRQX29 | Long             | EC               | CORP              | US        |       777 | NS      | $53232.27     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| LSI Industries Inc.                     | LSI Industries Inc.                            | CUSIP: 50216C108<br>LEI: 529900HY42OANH6BVT33 | Long             | EC               | CORP              | US        |      2348 | NS      | $42944.92     | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Bruker Corp.                            | Bruker Corp.                                   | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |      1596 | NS      | $77900.76     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Columbus McKinnon Corp.                 | Columbus McKinnon Corp.                        | CUSIP: 199333105<br>LEI: 549300W3HQB0HO1F3G69 | Long             | EC               | CORP              | US        |      3596 | NS      | $59118.24     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardelyx, Inc.                           | Ardelyx, Inc.                                  | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |      8467 | NS      | $49108.60     | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Masimo Corp.                            | Masimo Corp.                                   | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |       388 | NS      | $55262.84     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| FreightCar America, Inc.                | FreightCar America, Inc.                       | CUSIP: 357023100<br>LEI: 254900UEML23YM2EQB31 | Long             | EC               | CORP              | US        |      6347 | NS      | $51918.46     | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Qorvo, Inc.                             | Qorvo, Inc.                                    | CUSIP: 74736K101<br>LEI: 254900YAUJV2EUEVBR11 | Long             | EC               | CORP              | US        |       594 | NS      | $51018.66     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Open Text Corp.                         | Open Text Corp.                                | CUSIP: 683715106<br>LEI: 549300HP7ONDQODZJV16 | Long             | EC               | CORP              | CA        |      1632 | NS      | $54900.48     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Aehr Test Systems                       | Aehr Test Systems                              | CUSIP: 00760J108<br>LEI: 529900A4GWWZFRU2RE97 | Long             | EC               | CORP              | US        |      2161 | NS      | $49638.17     | 0.41%             |  |  |  | No            |                  1 | On Loan: —       |
| Allient Inc.                            | Allient Inc.                                   | CUSIP: 019330109<br>LEI: 549300I2LHAWYGNBPM97 | Long             | EC               | CORP              | US        |      1188 | NS      | $63985.68     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Cerus Corp.                             | Cerus Corp.                                    | CUSIP: 157085101<br>LEI: 254900BIEY9XIDA04Q21 | Long             | EC               | CORP              | US        |     41147 | NS      | $72418.72     | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| 8x8, Inc.                               | 8x8, Inc.                                      | CUSIP: 282914100<br>LEI: 254900XWSOC5U1BRW939 | Long             | EC               | CORP              | US        |     27380 | NS      | $53117.20     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Himax Technologies, Inc.                | Himax Technologies, Inc., ADR                  | CUSIP: 43289P106<br>LEI: 529900Z6XWS79D8T1X09 | Long             | EC               | CORP              | KY        |      6663 | NS      | $50372.28     | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson Outdoors Inc.                   | Johnson Outdoors Inc., Class A                 | CUSIP: 479167108<br>LEI: PJ44D8BWGDM6EUNG3Z13 | Long             | EC               | CORP              | US        |      1335 | NS      | $54721.65     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Neogen Corp.                            | Neogen Corp.                                   | CUSIP: 640491106<br>LEI: 549300HJT9FC36N4UW43 | Long             | EC               | CORP              | US        |      9366 | NS      | $56008.68     | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics, Inc.              | Sangamo Therapeutics, Inc.                     | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |    103605 | NS      | $47761.91     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| SIGA Technologies, Inc.                 | SIGA Technologies, Inc.                        | CUSIP: 826917106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6416 | NS      | $38880.96     | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| STRATTEC SECURITY Corp.                 | STRATTEC SECURITY Corp.                        | CUSIP: 863111100<br>LEI: 549300Z394OP8S8TSR40 | Long             | EC               | CORP              | US        |       823 | NS      | $61725.00     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilat Satellite Networks Ltd.           | Gilat Satellite Networks Ltd.                  | CUSIP: M51474118<br>LEI: 529900RVHDCYJ5YWHP12 | Long             | EC               | CORP              | IL        |      5766 | NS      | $67116.24     | 0.55%             |  |  |  | No            |                  1 | On Loan: —       |
| Cognex Corp.                            | Cognex Corp.                                   | CUSIP: 192422103<br>LEI: 549300JQTYZCLC43S226 | Long             | EC               | CORP              | US        |      1225 | NS      | $46672.50     | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| American Superconductor Corp.           | American Superconductor Corp.                  | CUSIP: 030111207<br>LEI: 549300S9YT8Z8LOK4452 | Long             | EC               | CORP              | US        |      1081 | NS      | $33608.29     | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Immersion Corp.                         | Immersion Corp.                                | CUSIP: 452521107<br>LEI: 529900AKNC1UAMQ2YB35 | Long             | EC               | CORP              | US        |      7676 | NS      | $54576.36     | 0.45%             |  |  |  | No            |                  1 | On Loan: —       |
| SolarEdge Technologies, Inc.            | SolarEdge Technologies, Inc.                   | CUSIP: 83417M104<br>LEI: 5493000K6Y58XXPDF853 | Long             | EC               | CORP              | US        |      1605 | NS      | $58630.65     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| InterDigital, Inc.                      | InterDigital, Inc.                             | CUSIP: 45867G101<br>LEI: 529900HQAUTC3VI47G64 | Long             | EC               | CORP              | US        |       200 | NS      | $71550.00     | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Lexicon Pharmaceuticals, Inc.           | Lexicon Pharmaceuticals, Inc.                  | CUSIP: 528872302<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48989 | NS      | $70054.27     | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapid7, Inc.                            | Rapid7, Inc.                                   | CUSIP: 753422104<br>LEI: 549300GNVG5D60KEYN14 | Long             | EC               | CORP              | US        |      2623 | NS      | $41128.64     | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp.                 | Arbutus Biopharma Corp.                        | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |     14529 | NS      | $64072.89     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Viavi Solutions Inc.                    | Viavi Solutions Inc.                           | CUSIP: 925550105<br>LEI: 5493006K3E3N1QOBF092 | Long             | EC               | CORP              | US        |      4782 | NS      | $85789.08     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Lumentum Holdings Inc.                  | Lumentum Holdings Inc.                         | CUSIP: 55024U109<br>LEI: 549300JLWRRC38DWEF52 | Long             | EC               | CORP              | US        |       408 | NS      | $132665.28    | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Commvault Systems, Inc.                 | Commvault Systems, Inc.                        | CUSIP: 204166102<br>LEI: 65T5VRP62VXG39YFML83 | Long             | EC               | CORP              | US        |       289 | NS      | $35691.50     | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Aclaris Therapeutics, Inc.              | Aclaris Therapeutics, Inc.                     | CUSIP: 00461U105<br>LEI: 5493000B2LQ9QTW1DF52 | Long             | EC               | CORP              | US        |     28095 | NS      | $79508.85     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| CytomX Therapeutics, Inc.               | CytomX Therapeutics, Inc.                      | CUSIP: 23284F105<br>LEI: 5493004VW2FW0QLL3345 | Long             | EC               | CORP              | US        |     26531 | NS      | $113552.68    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-12-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust II

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President